document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size font family time roman align center collaboration license agreement style margin margin bottom font size font family time roman align center dated march nbsp style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center aduro biotech style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center novartis pharmaceutical corporation style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan nowrap align right style border bottom solid page valign bottom nbsp style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article definition valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article collaboration governance valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman collaboration overview valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman joint steering committee valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman subcommittee valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman administration committee valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman decision making valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman alliance manager valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman general authority conduct party valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman operational separation valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article development valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman joint development valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman responsibility development cost valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman collaboration product company election valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman diligence standard conduct valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman development record report inspection valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman development subcontractor valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman material transfer valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article regulatory matter valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman overview valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman ownership regulatory filing regulatory approval right reference valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman regulatory meeting correspondence valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman collaboration product withdrawal recall valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman pharmacovigilance agreement valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article commercialization valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman overview diligence valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman commercialization valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman global branding strategy valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman commercialization cost valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman diligence standard conduct valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman commercialization subcontractor valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman reporting valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman commercialization standard conduct valign bottom nbsp nbsp nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan nowrap align right style border bottom solid page valign bottom nbsp style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article manufacture supply valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman overview valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman development manufacturing process certain clinical supply valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman commercial supply agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article grant right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman right granted novartis valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman right granted company valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman implied license valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman retained right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article financial term valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman upfront valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman milestone payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman royalty payment fixed royalty territory valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman profit share payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman third party obligation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman form payment currency valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman late payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman record audit right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman projection valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article intellectual property valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman ownership existing invention valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman disclosure invention inventorship determination valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman ownership program invention valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman filing prosecution maintenance defense company patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman filing prosecution maintenance defense novartis patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman filing prosecution maintenance defense joint invention valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman enforcement defense patent right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman personnel obligation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman trademark valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman mutual representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman representation warranty covenant company valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman representation warranty novartis valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman restriction technology valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman other representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan nowrap align right style border bottom solid page valign bottom nbsp style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article indemnification valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman indemnification company valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman indemnification novartis valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman indemnification procedure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman defense indemnification product liability claim valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman limitation liability valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman insurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article confidentiality valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman duty confidence valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman exception valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman authorized disclosure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman public disclosure data valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman publicity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman return confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article term termination valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman term valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman termination either party breach insolvency valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman termination either party safety reason valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman termination novartis convenience valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman effect expiration termination valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman right bankruptcy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman survival valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article change control valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman acquisition change control valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article governing dispute resolution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman governing valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman dispute resolution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman injunctive relief remedy breach exclusivity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article miscellaneous valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman entire agreement amendment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman force majeure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman notice valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman construction against drafter heading valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan nowrap align right style border bottom solid page valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman assignment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman performance affiliate valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman further assurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman compliance with valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman severability valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman waiver valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman relationship party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman third party beneficiary right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman english language valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman expense valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style margin left text indent font size font family time roman counterpart valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman exhibit style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit company patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit existing third party license table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit novartis patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit development cost sharing percentage table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit form sublicense agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit complete accurate list license assignment distribution other agreement relating company patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit list included within novartis know effective date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left width valign nbsp align left valign exhibit complete accurate list license assignment distribution other agreement relating novartis patent table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center collaboration license agreement style margin margin bottom text indent font size font family time roman this collaboration license agreement agreement entered into march nbsp execution date between aduro biotech delaware corporation having principal place business bancroft berkeley company novartis pharmaceutical corporation delaware corporation having principal place business located health plaza east hanover jersey novartis novartis company sometimes referred herein individually party collectively party style margin margin bottom font size font family time roman align center background style margin margin bottom text indent font size font family time roman whereas company owns otherwise control defined below company technology defined below experience expertise development human therapeutic product utilizing company technology style margin margin bottom text indent font size font family time roman whereas novartis global pharmaceutical company with expertise development manufacture commercialization human therapeutic product style margin margin bottom text indent font size font family time roman whereas each party wish collaborate with other party regarding certain development commercialization activity including drawing upon party complementary expertise resource each term condition forth herein style margin margin bottom text indent font size font family time roman therefore consideration foregoing premise mutual promise covenant condition contained this agreement party agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom text indent font size font family time roman used this agreement following initially capitalized term whether used singular plural form shall have meaning forth this article unless context this agreement otherwise requires nbsp word gender include each other gender nbsp word using singular plural number also include plural singular number respectively nbsp term hereunder hereof herein hereby derivative similar word refer this entire agreement nbsp term article section exhibit refer specified article section exhibit this agreement nbsp term include includes including shall deemed followed phrase without limitation nbsp refers calendar nbsp reference united state refer united state america nbsp word will shall construed have same meaning effect word shall nbsp reference herein person shall construed include person successor assigns nbsp definition reference agreement instrument other document herein shall construed referring such agreement instrument other document from time time amended supplemented otherwise modified subject restriction such amendment supplement modification forth herein accounting term used otherwise defined herein shall have meaning ascribed such term under applicable accounting standard applied party reference amount hereunder shall deemed dollar payment hereunder shall made dollar style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom text indent font size font family time roman accounting standard mean with respect company gaap mean with respect novartis ifrs each case generally consistently applied throughout applicable party organization style margin margin bottom text indent font size font family time roman acquired party meaning forth section nbsp style margin margin bottom text indent font size font family time roman acquiring party meaning forth definition change control style margin margin bottom text indent font size font family time roman meaning forth section nbsp style margin margin bottom text indent font size font family time roman action meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean antibody drug conjugate style margin margin bottom text indent font size font family time roman affiliate mean with respect person other person that control controlled under common control with such person purpose this definition control shall mean direct indirect ownership more than fifty percent nbsp share stock entitled vote election director case corporation more than fifty percent nbsp equity interest case other type legal entity status general partner partnership other arrangement whereby entity person control right control board director equivalent governing body corporation other entity ability cause direction management policy corporation other entity case entity organized under certain country maximum percentage ownership permitted foreign investor than fifty percent such case such lower percentage shall substituted preceding sentence provided that such case such foreign investor power direct management policy such entity notwithstanding foregoing purpose clarity none shall deemed affiliate company style margin margin bottom text indent font size font family time roman agreement meaning forth preamble hereto style margin margin bottom text indent font size font family time roman alliance manager meaning forth section nbsp style margin margin bottom text indent font size font family time roman amended cost sharing percentage meaning forth section nbsp style margin margin bottom text indent font size font family time roman annual development research plan budget meaning forth section nbsp style margin margin bottom text indent font size font family time roman applicable mean applicable statute rule regulation guideline order judgment ordinance governmental authority that effect from time time style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman auditor meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean biologics license application regulatory approval filed with united state pursuant section nbsp public health service nbsp successor statute regulation foreign equivalent thereof style margin margin bottom text indent font size font family time roman bpcia meaning forth section nbsp style margin margin bottom text indent font size font family time roman breaching party meaning forth section nbsp style margin margin bottom text indent font size font family time roman business mean other than nbsp saturday sunday nbsp bank other public holiday francisco california nbsp bank other public holiday basel switzerland nbsp with respect administrative matter calculation payment amount paid connection with this agreement nbsp nine nbsp consecutive beginning december nbsp style font size vertical align continuing through january nbsp extent already covered nbsp measurement number business applicable shall determined with respect eastern standard time eastern daylight time applicable style margin margin bottom text indent font size font family time roman calendar quarter mean respective period three nbsp consecutive calendar month ending march nbsp nbsp june nbsp nbsp september nbsp december nbsp style margin margin bottom text indent font size font family time roman calendar year mean period twelve nbsp consecutive calendar month ending december style margin margin bottom text indent font size font family time roman change control mean with respect party following event style margin margin bottom text indent font size font family time roman third party group third party acting concert becomes beneficial owner directly indirectly more than fifty percent nbsp total voting power capital stock then outstanding such party normally entitled vote election director other than pursuant consolidation merger falling within nbsp below provided however that event shall sale capital stock underwriter public offering capital stock company constitute change control style margin margin bottom text indent font size font family time roman such party consolidates with merges into another corporation entity corporation entity consolidates with merges into such party either event pursuant transaction series related transaction following which more than fifty percent nbsp total voting power capital stock outstanding surviving entity ultimate parent entity normally entitled vote election director held person held outstanding share such party immediately preceding such consolidation merger provided however that notwithstanding foregoing occurrence event described this clause nbsp this section nbsp with respect party shall change control either nbsp majority board director other governing body such party surviving entity ultimate parent entity applicable after three nbsp month following such event comprised member were member board director other governing body such party immediately prior such event nbsp majority executive officer style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman such party surviving entity ultimate parent entity applicable after three nbsp month following such event individual were executive officer such party immediately prior such event style margin margin bottom text indent font size font family time roman such party conveys transfer lease substantially asset related this agreement third party whether resulting from merger acquisition consolidation otherwise style margin margin bottom font size font family time roman purpose this definition change control only reference nbsp beneficial ownership other correlative term mean beneficial ownership defined rule under exchange nbsp group mean group defined exchange rule thereunder effect date hereof third party other corporation entity which effect change control with respect party shall referred acquiring party style margin margin bottom text indent font size font family time roman change control notice meaning forth section nbsp style margin margin bottom text indent font size font family time roman claim meaning forth section nbsp style margin margin bottom text indent font size font family time roman clinical study mean human clinical study conducted human subject that designed nbsp establish that pharmaceutical product reasonably safe continued testing nbsp investigate safety efficacy pharmaceutical product intended define warning precaution adverse reaction that associated with pharmaceutical product dosage range prescribed nbsp support regulatory approval pricing approval label expansion such pharmaceutical product without limiting foregoing clinical study includes phase clinical study phase clinical study phase clinical study phase clinical study phase clinical study style margin margin bottom text indent font size font family time roman mean chemistry manufacturing control style margin margin bottom text indent font size font family time roman code meaning forth section nbsp style margin margin bottom text indent font size font family time roman collaboration meaning forth section nbsp style margin margin bottom text indent font size font family time roman collaboration molecule mean agonist molecular target known stimulator interferon gene sting which agonist owned controlled either party effective date either both party during term style margin margin bottom text indent font size font family time roman collaboration product mean pharmaceutical product composition containing collaboration molecule style margin margin bottom text indent font size font family time roman combination lead party meaning forth section style margin margin bottom text indent font size font family time roman combination regimen meaning forth section style margin margin bottom text indent font size font family time roman commencement date meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercial sharing percentage mean with respect given reference territory given party style margin margin bottom text indent font size font family time roman such party company nbsp fifty percent nbsp nbsp forty five percent nbsp european profit split country nbsp forty five percent nbsp japan including potentially adjusted pursuant section nbsp style margin margin bottom text indent font size font family time roman such party novartis nbsp fifty percent nbsp nbsp fifty five percent nbsp european profit split country nbsp fifty five percent nbsp japan including potentially adjusted pursuant section nbsp style margin margin bottom text indent font size font family time roman commercialization mean process activity directed market promote detail distribute import export offer sell sell product conduct other commercialization activity including activity preparation commercial launch such product retaining pricing reimbursement market access commercialize correlative meaning style margin margin bottom text indent font size font family time roman commercialization cost mean cost expense incurred behalf party affiliate which cost expense consistent with applicable commercialization plan accordance with expense recognition provision accounting standard commercialization cost shall include avoidance doubt contract consultant deployed detailing marketing activity should considered cost style margin margin bottom text indent font size font family time roman commercialization cost calculation report meaning forth section nbsp style margin margin bottom text indent font size font family time roman commercialization cost report meaning forth section nbsp style margin margin bottom text indent font size font family time roman commercialization plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman commercially reasonable effort mean with respect objective those reasonable diligent good faith effort accomplish such objective party would customarily accomplish similar objective under similar circumstance which than those effort used such party development manufacture commercialization project case with such party compound product having comparable commercial potential stage development medical scientific technical regulatory profile intellectual property protection taking into account commercially relevant factor time such effort expended when taking into account profitability other commercial consideration commercially relevant factor each party shall take into account that portion profit shared with other party royalty paid other party will instead treat such payment amount that would retained such party extent that party performance obligation hereunder adversely affected other party failure perform obligation under this agreement supply agreement including supply agreement referenced section nbsp then impact such performance style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman failure will taken into account determining whether that party used commercially reasonable effort perform such affected obligation only extent such other party performance failure cause that party failure meet such obligation style margin margin bottom text indent font size font family time roman commercially relevant factor mean with respect collaboration product including applicable such collaborative product relevant factor that affect development regulatory approval commercialization such collaboration product including applicable safety efficacy quality stability product profile including product modality category mechanism action stage development life cycle status development regulatory approval manufacturing commercialization cost risk feasibility manufacture likelihood obtaining regulatory approval including satisfactory price approval timing such approval current guidance requirement regulatory approval current projected regulatory status labeling anticipated labeling then current competitive environment external party likely competitive environment external party time projected entry into market taking into consideration other collaboration product other product party past performance present future market potential existing projected pricing sale reimbursement profitability pricing reimbursement change relevant country proprietary position strength duration patent protection anticipated exclusivity other scientific technical regulatory commercial factor that decision making party reasonably belief relevant such collaboration product style margin margin bottom text indent font size font family time roman company meaning forth preamble this agreement style margin margin bottom text indent font size font family time roman company disclosure schedule mean disclosure schedule prepared company delivered company novartis effective date style margin margin bottom text indent font size font family time roman company indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman company know mean existing company know later acquired company know that reasonably necessary useful that actually used either party their affiliate development manufacture commercialization collaboration molecule collaboration product undertake research relating sting agonist under this agreement company know shall include nbsp such know owned controlled company affiliate effective date existing company know nbsp such know that first becomes owned controlled company affiliate after effective date that company elect designate later acquired company know avoidance doubt company know excludes joint invention joint know novartis know style margin margin bottom text indent font size font family time roman company patent mean existing company patent later acquired company patent having claim covering collaboration molecule collaboration product having claim that reasonably necessary useful that actually used party affiliate development manufacture commercialization collaboration molecule collaboration product company patent shall include nbsp such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman patent right owned controlled company affiliate effective date including patent right identified exhibit attached hereto existing company patent nbsp such patent right that first become owned controlled company affiliate after effective date that company elect designate later acquired company patent avoidance doubt company patent exclude joint patent novartis patent style margin margin bottom text indent font size font family time roman company technology mean company patent company know company interest joint know joint patent joint invention style margin margin bottom text indent font size font family time roman competing product mean pharmaceutical product containing other than collaboration product style margin margin bottom text indent font size font family time roman confidential information mean with respect disclosing party affiliate know other proprietary confidential information data financial commercial technical nature which such disclosing party affiliate supplied otherwise made available recipient party affiliate whether made available orally writing electronic form style margin margin bottom text indent font size font family time roman continuing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman control controlled mean with respect know patent right other intellectual property right other proprietary trade secret information legal authority right whether ownership license otherwise other than pursuant this agreement party affiliate described below future acquirer grant license sublicense under such know patent right other intellectual property right other proprietary trade secret information another person otherwise disclose such proprietary trade secret information another person extent forth this agreement without requiring consent third party breaching term agreement with third party misappropriating proprietary trade secret information third party notwithstanding foregoing intellectual property right controlled future acquirer party shall treated controlled party affiliate purpose this agreement extent only extent that such intellectual property nbsp controlled such future acquirer such party immediately prior time such future acquirer qualifies such other than pursuant license other grant right such party nbsp controlled such future acquirer subsequent time that such future acquirer qualifies such controlled such party affiliate immediately prior time such future acquirer qualifies such come under control such future acquirer reference access company technology novartis technology applicable such future acquirer style margin margin bottom text indent font size font family time roman controlling party meaning forth section nbsp style margin margin bottom text indent font size font family time roman cost good sold mean cost incurred each party actual manufacturing collaboration product established regular standard basis accordance with accounting standard consistently applied each party expressed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman unit basis party agree that shall determined pursuant full transparency detailed cost calculation according principle open book agreed upon advance both party shall include following element style margin margin bottom margin left font size font family time roman cost style margin margin bottom margin left font size font family time roman direct labor cost production employee collaboration product style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman cost equipment shall based overhead shall allocated production proportionate usage manufacturing facility actual manufacturing product using appropriate allocation such space occupied headcount cost underutilization idle capacity included overhead shall include example only style margin margin bottom margin left font size font family time roman cost approved third party contract manufacturer such cost will include actual amount paid taking into account benefit price reduction payment term discount other reimbursement such volume discount that applicable such purchase style margin margin bottom text indent font size font family time roman cover covering covered mean with respect given product given country territory that absence ownership license granted under valid claim manufacture offer sale sale importation such product such country would infringe such valid claim case claim that issued would infringe such claim were issue without modification style margin margin bottom text indent font size font family time roman develop development mean drug research development activity including compound discovery characterization test method development stability testing assay development audit development toxicology formulation process development quality assurance quality control development statistical analysis work companion diagnostics nonclinical study clinical study health technology assessment packaging development regulatory affair preparation filing prosecution maintenance regulatory filing regulatory approval including post approval commitment style margin margin bottom text indent font size font family time roman development research plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman development research program mean development activity early research well collaboration molecule collaboration product under applicable development research plan each case accordance with term this agreement style margin margin bottom text indent font size font family time roman development cost mean cost incurred either party accordance with development research budget after effective date research style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman development collaboration product pursuant development research plan development activity context requires comprising nbsp connection with development nbsp that deemed constitute nbsp nbsp under term this agreement style margin margin bottom text indent font size font family time roman development cost calculation report meaning forth section nbsp style margin margin bottom text indent font size font family time roman development cost report meaning forth section nbsp style margin margin bottom text indent font size font family time roman development cost sharing percentage meaning forth section nbsp style margin margin bottom text indent font size font family time roman development reimbursement payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman disclosed invention meaning forth section nbsp style margin margin bottom text indent font size font family time roman disclosing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman discontinuing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman dispute resolution officer mean designee style margin margin bottom text indent font size font family time roman mean united state department justice style margin margin bottom text indent font size font family time roman draft meaning forth section nbsp style margin margin bottom text indent font size font family time roman early research mean development activity initiation toxicology study whether research relating sting agonist relating particular collaboration molecule potential collaboration product style margin margin bottom text indent font size font family time roman effective date mean style margin margin bottom text indent font size font family time roman election notice meaning forth section style margin margin bottom text indent font size font family time roman mean european medicine agency successor entity thereto style margin margin bottom text indent font size font family time roman encumbrance mean claim charge equitable interest hypothecation lien mortgage pledge option license assignment power sale retention title right emption right first refusal security interest kind style margin margin bottom text indent font size font family time roman european profit split country mean major european country greece switzerland russia style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman exchange mean security exchange amended rule regulation promulgated thereunder style margin margin bottom text indent font size font family time roman execution date meaning forth preamble hereto style margin margin bottom text indent font size font family time roman executive officer mean with respect party officer such party such term defined rule under exchange style margin margin bottom text indent font size font family time roman existing third party license mean agreement entered into company with third party each existing third party licensor prior effective date including amendment thereto effective date pursuant which such third party granted company license patent right know that controlled company affiliate effective date that necessary useful research develop manufacture commercialize market import export sell offer sale otherwise collaboration product purpose field existing third party license execution date listed exhibit style margin margin bottom text indent font size font family time roman fcpa meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean united state federal food drug cosmetic amended style margin margin bottom text indent font size font family time roman mean united state food drug administration successor entity thereto style margin margin bottom text indent font size font family time roman field mean oncology human including immuno oncology cancer vaccine human style margin margin bottom text indent font size font family time roman first commercial sale mean first sale third party applicable collaboration product certain country after regulatory approval reasonably required sale reimbursement available collaboration product have been obtained such country provided that sale such applicable collaboration product arising from named patient compassionate other similar program applicable country will considered first commercial sale style margin margin bottom text indent font size font family time roman fixed royalty territory mean country throughout territory outside profit share territory style margin margin bottom text indent font size font family time roman force majeure meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean full time dedicated executive officer administrative person year case than full time dedicated administrative person full time equivalent administrative person year based upon total hour year development manufacturing commercialization work undertaken administrative personnel company novartis their respective affiliate applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cost given period mean product nbsp total ftes proportionately basis dedicated party affiliate particular period direct performance activity allocated such party hereunder nbsp rate style margin margin bottom text indent font size font family time roman rate mean rate which prorated daily basis necessary annum with respect activity conducted pursuant this agreement rate shall used only with respect development cost trademark cost other cost including commercialization cost which shall have different rate intended approximate actual cost reasonably agreed party rate intended cover cost salary benefit infrastructure cost including informational technology cost travel general laboratory office supply postage insurance training other general expense overhead item rate increased reset with mutual written consent both party style margin margin bottom text indent font size font family time roman future acquirer mean third party change control transaction involving party style margin margin bottom text indent font size font family time roman global branding strategy meaning forth section nbsp style margin margin bottom text indent font size font family time roman governmental authority mean court agency department authority other instrumentality multi national national state county city province other political subdivision style margin margin bottom text indent font size font family time roman gross profit mean each region within profit share territory european profit split country japan sale such region cost good sold such region sale collaboration product party third party such region style margin margin bottom text indent font size font family time roman mean style margin margin bottom text indent font size font family time roman ifrs mean international financial reporting standard consistently applied style margin margin bottom text indent font size font family time roman mean investigational drug application filed with corresponding application investigation collaboration product other country group country defined applicable filed with regulatory authority given country group country style margin margin bottom text indent font size font family time roman indemnitee meaning forth section nbsp style margin margin bottom text indent font size font family time roman indemnitor meaning forth section nbsp style margin margin bottom text indent font size font family time roman insolvency event mean relation either party following nbsp filing such party court agency pursuant statute regulation state country petition bankruptcy insolvency reorganization style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman arrangement appointment receiver trustee bankrupt party asset nbsp person proposing written agreement composition extension bankrupt party debt nbsp such party being served with involuntary petition against bankrupt party filed insolvency proceeding such petition shall dismissed within sixty nbsp after filing thereof nbsp such party proposing being party dissolution liquidation such party nbsp such party making general assignment benefit creditor style margin margin bottom text indent font size font family time roman joint commercialization committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint intellectual property committee jipc meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint invention meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint know meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint patent meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint research development committee jrdc meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint steering committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint supply committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman know mean technical information know data including invention whether patentable discovery trade secret specification instruction process formula material expertise other technology applicable compound formulation composition product their manufacture development registration commercialization method assaying testing them process their manufacture formulation containing them composition incorporating comprising them including biological chemical pharmacological biochemical toxicological pharmaceutical physical analytical safety quality control manufacturing preclinical clinical data instruction process formula expertise information regulatory filing copy thereof relevant development manufacture commercialization which useful studying testing development production formulation product intermediate synthesis thereof style margin margin bottom text indent font size font family time roman later acquired company know meaning forth section nbsp style margin margin bottom text indent font size font family time roman later acquired company patent meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman later acquired company technology mean later acquired company patent later acquired company know style margin margin bottom text indent font size font family time roman later acquired novartis know meaning forth section nbsp style margin margin bottom text indent font size font family time roman later acquired novartis patent meaning forth section nbsp style margin margin bottom text indent font size font family time roman later acquired novartis technology mean later acquired novartis patent later acquired novartis know style margin margin bottom text indent font size font family time roman lead commercialization party meaning forth section style margin margin bottom text indent font size font family time roman lead regulatory party meaning forth section nbsp style margin margin bottom text indent font size font family time roman loss meaning forth section nbsp style margin margin bottom text indent font size font family time roman major european country mean each united kingdom france germany italy spain style margin margin bottom text indent font size font family time roman manufacture mean with respect collaboration molecule collaboration product synthesize express manufacture process formulate package label hold store quality control test release such collaboration molecule collaboration product manufacturing mean those activity that relate synthesis expression manufacture processing formulation packaging labeling holding storing quality control testing release such collaboration molecule collaboration product including manufacturing process development scale validation qualification audit clinical commercial manufacturing facility bulk collaboration product fill finish work related quality assurance technical support activity style margin margin bottom text indent font size font family time roman marketing authorization application mean application authorization market collaboration product country group country outside united state defined applicable filed with regulatory authority given country group country style margin margin bottom text indent font size font family time roman mark meaning forth section nbsp style margin margin bottom text indent font size font family time roman material receiving party meaning forth section nbsp style margin margin bottom text indent font size font family time roman material meaning forth section nbsp style margin margin bottom text indent font size font family time roman milestone meaning forth section nbsp style margin margin bottom text indent font size font family time roman milestone payment meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman mutual consent matter mean those matter defined mutual consent matter section nbsp other matter that party expressly mutually agree this agreement otherwise writing designate mutual consent matter under this agreement with respect each mutual consent matter each party must expressly provide consent including such consent delivered electronic transmission given duly authorized representative such party style margin margin bottom text indent font size font family time roman mean with respect collaboration product drug application applicable united state authorization market such collaboration product defined applicable filed with corresponding application other country group country style margin margin bottom text indent font size font family time roman sale mean sale recorded lead commercialization party affiliate sublicensees excluding distributor wholesaler collaboration product sold third party other than sublicensees determined accordance with accounting standard consistently applied deduction direct expense related sale collaboration product distribution warehousing expense uncollectible amount previously sold product provided that deduction such item shall made under clause nbsp through viii nbsp below deduction booked accrual basis lead commercialization party affiliate under accounting standard calculate recorded sale from gross sale include following each case extent actually accrued discounted credited applicable without duplication style margin margin bottom margin left font size font family time roman customary trade cash discount style margin margin bottom margin left font size font family time roman amount repaid credited reason defect rejection recall return style margin margin bottom margin left font size font family time roman rebate chargebacks customer third party including without limitation medicare medicaid managed healthcare similar type rebate style margin margin bottom margin left font size font family time roman amount recorded gross revenue good provided customer free style margin margin bottom margin left font size font family time roman amount provided credited customer through coupon other discount program style margin margin bottom margin left font size font family time roman delayed ship order credit discount payment related impact price increase between purchase shipping date style margin margin bottom margin left font size font family time roman service payment customer separable service including compensation maintaining agreed inventory level providing information extent required under lead commercialization party accounting standard style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman viii pharmaceutical excise such those imposed united state patient protection affordable care nbsp other comparable style margin margin bottom margin left font size font family time roman viii other reduction specifically identifiable amount deducted reason substantially similar those listed clause nbsp through viii nbsp above required under lead commercialization party accounting standard style margin margin bottom text indent font size font family time roman with respect calculation sale style margin margin bottom text indent font size font family time roman sale only include value charged invoiced first length sale third party sale between among lead commercialization party affiliate sublicensees shall disregarded purpose calculating sale provided that neither lead commercialization party affiliate sublicensees recognize revenue from third party following connection with such sale which case such third party revenue shall included sale style margin margin bottom text indent font size font family time roman collaboration product delivered third party before being invoiced invoiced sale will calculated time revenue recognition criterion under lead commercialization party accounting standard style margin margin bottom text indent font size font family time roman third party license meaning forth section style margin margin bottom text indent font size font family time roman breaching party meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean style margin margin bottom text indent font size font family time roman nonclinical study mean human study including preclinical study toxicology study collaboration product style margin margin bottom text indent font size font family time roman novartis meaning forth preamble this agreement style margin margin bottom text indent font size font family time roman novartis existing fixed royalty territory payment meaning forth section style margin margin bottom text indent font size font family time roman novartis fixed royalty territory payment meaning forth section style margin margin bottom text indent font size font family time roman novartis indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman novartis know mean existing novartis know later acquired novartis know that reasonably necessary useful that actually used either party their affiliate development manufacture commercialization collaboration molecule collaboration product undertake research relating sting agonist under this agreement novartis know shall include nbsp such know owned controlled novartis affiliate effective date existing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman novartis know nbsp such know that first becomes owned controlled novartis affiliate after effective date that company elect designate later acquired novartis know avoidance doubt novartis know excludes joint invention joint know company know style margin margin bottom text indent font size font family time roman novartis patent mean existing novartis patent later acquired novartis patent having claim covering collaboration molecule collaboration product having claim that reasonably necessary useful that actually used party affiliate development manufacture commercialization collaboration molecule collaboration product novartis patent shall include nbsp such patent right owned controlled novartis affiliate effective date including patent right identified exhibit attached hereto existing novartis patent nbsp such patent right that first become owned controlled novartis affiliate after effective date that novartis elect designate later acquired novartis patent avoidance doubt novartis patent exclude joint patent company patent style margin margin bottom text indent font size font family time roman novartis product liability claim mean claim product liability damage person property death resulting from consumption collaboration product fixed royalty territory style margin margin bottom text indent font size font family time roman novartis promotion territory mean with respect each collaboration product country territory other than provided however shall become part novartis promotion territory included fixed royalty territory pursuant election company under section style margin margin bottom text indent font size font family time roman novartis technology mean novartis patent novartis know novartis interest joint know joint patent joint invention style margin margin bottom text indent font size font family time roman development meaning forth section nbsp style margin margin bottom text indent font size font family time roman pocket cost mean with respect activity pursuant this agreement expense paid payable either party affiliate third party other than employee such party affiliate extent have been recorded accordance with accounting standard avoidance doubt include style margin margin bottom text indent font size font family time roman overall development research plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman party party meaning forth preamble this agreement style margin margin bottom text indent font size font family time roman patent right mean right interest issued patent pending patent application country jurisdiction region including inventor certificate utility model including provisionals provisionals substitution continuation continuation part divisionals renewal patent granted thereon style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman reissue reexamination extension confirmation revalidations registration patent addition thereof including supplementary protection certificate pediatric exclusivity period foreign equivalent foregoing style margin margin bottom text indent font size font family time roman payee meaning forth section style margin margin bottom text indent font size font family time roman payment meaning forth section style margin margin bottom text indent font size font family time roman payor meaning forth section style margin margin bottom text indent font size font family time roman person mean individual partnership limited liability company firm corporation association trust unincorporated organization other entity style margin margin bottom text indent font size font family time roman phase nbsp clinical study mean clinical study that generally provides introduction into human pharmaceutical product with primary purpose determining safety metabolism pharmacokinetic property clinical pharmacology such product manner that generally consistent with amended successor regulation analogous applicable outside united state applicable provided however phase clinical study include study generally characterized exploratory study cder guidance industry investigator reviewer exploratory study january irrespective whether such study actually performed united state under style margin margin bottom text indent font size font family time roman phase nbsp clinical study mean clinical study principal purpose which make preliminary determination whether pharmaceutical product safe intended obtain sufficient information about such product efficacy manner that generally consistent with amended successor regulation analogous applicable outside united state applicable permit design further clinical study style margin margin bottom text indent font size font family time roman phase nbsp clinical study mean phase clinical study style margin margin bottom text indent font size font family time roman phase nbsp clinical study mean pivotal clinical study with defined dose defined pharmaceutical product designed ascertain efficacy safety such product manner that generally consistent with amended successor regulation analogous applicable outside united state applicable clarity pivotal study phase clinical study style margin margin bottom text indent font size font family time roman phase clinical study mean human clinical trial which conducted product after regulatory approval product been obtained from appropriate regulatory authority includes nbsp trial conducted voluntarily enhancing marketing scientific knowledge approved indication nbsp trial conducted after regulatory approval request requirement regulatory authority condition previously granted regulatory approval including study conducted response pediatric written request condition approval study style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman phrma code mean phrma code interaction with health care professional style margin margin bottom text indent font size font family time roman pivotal study mean phase clinical study collaboration product other clinical study such collaboration product which intended sufficient support regulatory approval such collaboration product particular country which either clinical study conducted support regulatory approval more country including such country that conducted specifically support regulatory approval such country style margin margin bottom text indent font size font family time roman potential combination product meaning forth section style margin margin bottom text indent font size font family time roman pricing approval mean with respect country jurisdiction where governmental authority authorizes reimbursement approves determines pricing pharmaceutical product receipt required make such authorization approval determination effective publication transitory reimbursement authorization pricing approval determination case together with health technology assessment that required such country jurisdiction nbsp clarity authorization reimbursement that come into effect while regulatory authority considers longer term more permanent reimbursement pricing shall considered transitory last greater than twelve nbsp month style margin margin bottom text indent font size font family time roman product liability claim mean claim product liability damage person property death resulting from consumption collaboration product territory style margin margin bottom text indent font size font family time roman product liability share meaning forth section nbsp style margin margin bottom text indent font size font family time roman profit share territory mean subject adjustment pursuant section nbsp following three nbsp region within territory nbsp nbsp european profit split country japan style margin margin bottom text indent font size font family time roman publication meaning forth section nbsp style margin margin bottom text indent font size font family time roman purpose meaning forth section nbsp style margin margin bottom text indent font size font family time roman recipient party meaning forth section nbsp style margin margin bottom text indent font size font family time roman region mean nbsp nbsp european profit split country nbsp japan applicable style margin margin bottom text indent font size font family time roman regulatory approval mean with respect collaboration product country jurisdiction approval including pricing approval registration license authorization from regulatory authority other governmental authority country other jurisdiction that necessary offer sale market sell such collaboration product such country jurisdiction style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman regulatory authority mean governmental authority responsible granting regulatory approval collaboration product including corresponding national regional regulatory authority style margin margin bottom text indent font size font family time roman regulatory filing mean with respect collaboration product submission regulatory authority appropriate regulatory application shall include submission regulatory advisory board marketing authorization application supplement amendment thereto avoidance doubt regulatory filing includes corresponding application other country group country style margin margin bottom text indent font size font family time roman royalty term mean collaboration product collaboration product country country basis period starting effective date ending later nbsp twelve nbsp year after first commercial sale such collaboration product such country nbsp date expiration lapse invalidation last valid claim whether such valid claim valid claim under company patent novartis patent joint patent covering such collaboration product such country nbsp expiration data exclusivity conferred competent regulatory authority such collaboration product such country style margin margin bottom text indent font size font family time roman sale nbsp profit share report mean with respect calendar quarter written report showing each nbsp gross profit sale each collaboration product each country each profit share territory during such calendar quarter nbsp amount payable such party under section nbsp united state dollar which shall have accrued hereunder with respect such gross profit including exchange rate used calculate such amount style margin margin bottom text indent font size font family time roman sale nbsp royalty report mean with respect calendar quarter written report showing each nbsp sale each collaboration product each country fixed royalty territory during such calendar quarter nbsp royalty payable novartis under section nbsp united state dollar which shall have accrued hereunder with respect such sale fixed royalty territory including exchange rate used calculate such royalty style margin margin bottom text indent font size font family time roman sale representative mean pharmaceutical sale representative engaged party affiliate conduct detailing other sale promotional effort with respect collaboration product style margin margin bottom text indent font size font family time roman mean security exchange commission style margin margin bottom text indent font size font family time roman second request meaning forth section style margin margin bottom text indent font size font family time roman selected molecule meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman shared existing third party payment meaning forth section style margin margin bottom text indent font size font family time roman shared product liability claim mean claim product liability damage person property death resulting from consumption collaboration product profit share territory style margin margin bottom text indent font size font family time roman sting meaning forth section style margin margin bottom text indent font size font family time roman subcommittee meaning forth section nbsp style margin margin bottom text indent font size font family time roman sunshine meaning forth section nbsp style margin margin bottom text indent font size font family time roman term meaning forth section nbsp style margin margin bottom text indent font size font family time roman territory mean country world style margin margin bottom text indent font size font family time roman third party mean person other than party affiliate party style margin margin bottom text indent font size font family time roman trademark cost mean cost pocket cost including filing maintenance expense each case incurred connection with establishment maintenance right under trademark applicable collaboration product territory including cost territory trademark filing registration action enforce maintain territory trademark other territory trademark proceeding style margin margin bottom text indent font size font family time roman transfer record meaning forth section nbsp style margin margin bottom text indent font size font family time roman transferring party meaning forth section nbsp style margin margin bottom text indent font size font family time roman bribery meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean united state america territory possession style margin margin bottom text indent font size font family time roman gaap mean generally accepted accounting principle consistently applied style margin margin bottom text indent font size font family time roman valid claim mean with respect particular country territory nbsp claim issued unexpired patent such country covering applicable product each case that been revoked held unenforceable unpatentable invalid decision court other governmental agency competent jurisdiction that appealable been appealed within time allowed appeal that been abandoned disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise nbsp claim patent application such country covering applicable product each case that been pending than from earliest date which such patent application claim priority which claim filed being prosecuted good faith been cancelled withdrawn abandoned finally rejected style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman administrative agency action from which appeal taken where product referred this definition collaboration product term patent clause nbsp this definition shall mean company patent novartis patent joint patent phrase claim patent application clause nbsp this definition shall mean claim patent application included company patent novartis patent joint patent style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center collaboration governance style margin margin bottom text indent font size font family time roman collaboration overview party desire intend collaborate with respect development commercialization collaboration product field territory extent forth this agreement collaboration connection with participation collaboration each party shall endeavor good faith maximize economic value collaboration product party nbsp style margin margin bottom text indent font size font family time roman joint steering committee style margin margin bottom text indent font size font family time roman establishment within after effective date party shall establish term joint steering committee joint steering committee that will have responsibility overall coordination oversight party activity under collaboration this agreement each party shall have right appoint three nbsp representative soon practicable following effective date event more than following effective date each party shall have right designate initial representative each party shall free change representative notice other party send substitute representative meeting provided however that each party shall ensure that time during existence representative have appropriate expertise seniority including least nbsp member senior management then current stage development commercialization collaboration product have sufficient authority behalf such party with respect matter within purview each party representative substitute representative shall bound obligation confidentiality forth article style margin margin bottom text indent font size font family time roman specific responsibility addition overall responsibility monitoring providing general oversight with respect party activity under collaboration shall particular have following responsibility style margin margin bottom text indent font size font family time roman periodic review overall goal strategy progress each development research program adjusting such goal strategy each development research program needed style margin margin bottom text indent font size font family time roman with respect each collaboration product reviewing approving development research plan making revision update amendment development research plan annual development research plan budget such collaboration product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman reviewing approving commercialization plan related budget profit share territory style margin margin bottom text indent font size font family time roman with respect each collaboration product reviewing approving development such collaboration product style margin margin bottom text indent font size font family time roman periodic review overall goal strategy progress commercialization collaboration product style margin margin bottom text indent font size font family time roman reviewing approving global branding strategy each collaboration product prepared style margin margin bottom text indent font size font family time roman reviewing approving third party license pursuant section nbsp style margin margin bottom text indent font size font family time roman viii coordinating reporting actual financial result collaboration product ensure that each party timely comply with reporting obligation style margin margin bottom text indent font size font family time roman resolution matter presented dispute raised joint research development committee joint commercialization committee joint intellectual property committee joint supply committee other subcommittee each case that within scope responsibility delegated respective subcommittee under this agreement subject final decision making authority forth section nbsp style margin margin bottom text indent font size font family time roman performing such other function appropriate directing each subcommittee perform such other function appropriate further purpose this agreement collaboration each case mutually agreed writing party style margin margin bottom text indent font size font family time roman subcommittee establish disband such subcommittee deemed necessary perform activity function delegated hereunder each subcommittee each such subcommittee shall consist same number representative designated each party which number provided this agreement shall mutually agreed party each party shall free change subcommittee representative notice other party send substitute representative subcommittee meeting provided however that each party shall ensure that time during existence subcommittee representative such subcommittee have appropriate expertise seniority then current stage development commercialization applicable collaboration product have sufficient authority behalf such party with respect matter within purview relevant subcommittee each party subcommittee representative substitute such representative shall bound obligation confidentiality forth article initial subcommittee will joint research development committee joint intellectual property committee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman joint research development committee style margin margin bottom text indent font size font family time roman establishment within after establishment shall establish single joint research development committee each joint research development committee jrdc that shall responsible overall coordination oversight early research well each development research program each party shall entitled appoint nbsp representative jrdc soon practicable following effective date event more than following effective date each party shall designate initial representative jrdc style margin margin bottom text indent font size font family time roman specific responsibility jrdc with respect applicable development research program jrdc shall have following responsibility subject oversight accordance with section nbsp style margin margin bottom text indent font size font family time roman discussing preparing recommending review approval development research plan revision update amendment development research plan annual development research plan budget such development research program style margin margin bottom text indent font size font family time roman discussing preparing recommending review approval development style margin margin bottom text indent font size font family time roman overseeing coordinating implementing such development research program style margin margin bottom text indent font size font family time roman providing forum party discus such development research program style margin margin bottom text indent font size font family time roman providing forum party discus appropriate allocation cost expense under this agreement such development research program style margin margin bottom text indent font size font family time roman reporting financial matter style margin margin bottom text indent font size font family time roman monitoring spending party under each development research plan style margin margin bottom text indent font size font family time roman performing such other function appropriate further purpose collaboration this agreement each case with respect such development research program mutually agreed writing party directed style margin margin bottom text indent font size font family time roman joint commercialization committee style margin margin bottom text indent font size font family time roman establishment appropriate time decided shall establish joint commercialization committee joint style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman commercialization committee that shall responsible overseeing reviewing coordinating style margin margin bottom font size font family time roman commercialization collaboration product territory each party shall have right appoint nbsp representative avoidance doubt notwithstanding other provision this agreement shall have decision making responsibility with respect commercialization collaboration product style margin margin bottom text indent font size font family time roman specific responsibility shall have following responsibility subject oversight accordance with section nbsp style margin margin bottom text indent font size font family time roman reviewing commenting each commercialization plan submitted accordance with section nbsp including budget contained therein style margin margin bottom text indent font size font family time roman preparing recommending review approval commercialization plan related budget profit share territory style margin margin bottom text indent font size font family time roman setting rate commercialization activity undertaken administrative personnel company novartis their respective affiliate style margin margin bottom text indent font size font family time roman providing forum party discus commercialization collaboration product style margin margin bottom text indent font size font family time roman performing such other function appropriate further purpose collaboration this agreement each case with respect commercialization collaboration product mutually agreed writing party directed style margin margin bottom text indent font size font family time roman joint intellectual property committee style margin margin bottom text indent font size font family time roman establishment within after establishment shall establish joint intellectual property committee joint intellectual property committee jipc that shall responsible overseeing reviewing coordinating matter related company technology novartis technology pursuant article each party shall have right appoint nbsp representative jipc each which shall have appropriate experience expertise with intellectual property matter relating pharmaceutical product technology style margin margin bottom text indent font size font family time roman specific responsibility jipc jipc shall have following responsibility subject oversight accordance with section nbsp style margin margin bottom text indent font size font family time roman with respect joint invention application application basis determining what claim will prosecuted what claim application will abandoned style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman conducting periodic portfolio review propose strategy maximize strength patent portfolio cost effectiveness preparation filing prosecution maintenance company patent novartis patent they relate development manufacture commercialization collaboration product style margin margin bottom text indent font size font family time roman coordinating decision making between party matter mutual concern forth article style margin margin bottom text indent font size font family time roman performing such other function appropriate further purpose collaboration this agreement each case with respect intellectual property matter arising hereunder mutually agreed writing party directed style margin margin bottom text indent font size font family time roman joint supply committee prior initiation phase nbsp clinical study first collaboration product shall establish joint supply committee joint supply committee that shall responsible overseeing reviewing coordinating manufacture supply collaboration product manner consistent with further provided commercial supply agreement entered into pursuant section nbsp style margin margin bottom text indent font size font family time roman administration committee style margin margin bottom text indent font size font family time roman chairperson style margin margin bottom text indent font size font family time roman each subcommittee shall have nbsp chairperson with company novartis alternating right appoint such chairperson such subcommittee applicable annual basis with company having initial right such chairperson appointment style margin margin bottom text indent font size font family time roman chairperson shall have greater authority than other representative such subcommittee applicable chairperson shall have right call meeting respective subcommittee applicable shall have following responsibility nbsp preparing issuing minute each such meeting within thereafter nbsp ensuring that decision making delegated such subcommittee applicable carried accordance with section nbsp nbsp preparing circulating agenda upcoming meeting respective subcommittee applicable style margin margin bottom text indent font size font family time roman meeting each subcommittee shall each hold least nbsp meeting calendar quarter such time during such calendar quarter applicable subcommittee chairperson elect meeting subcommittee respectively shall effective only least nbsp representative each party present subcommittee meet either nbsp person such varied location applicable subcommittee mutually agree nbsp audio video teleconference provided that than nbsp meeting during each calendar year shall conducted person other representative each party involved with collaboration product attend subcommittee meeting font style white space nowrap voting font participant style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman provided that such representative subject confidentiality provision forth article additional meeting subcommittee also held with consent each party required under this agreement meeting nbsp more subcommittee combined same session provided that required member such subcommittee provided this section nbsp attendance each party shall responsible expense incurred connection with participating such meeting style margin margin bottom text indent font size font family time roman appointment right appointment member subcommittee right each party obligation shall deliverable referenced existing authoritative accounting literature each party shall free determine appoint member subcommittee failure party appoint member subcommittee thereof shall constitute breach this agreement unless until such member appointed party that made requisite appointment unilaterally discharge role subcommittee thereof which member were appointed provided that neither party shall unilaterally discharge role subcommittee thereof permitted under this section nbsp unless other party appointed member within after first party completed appointment member style margin margin bottom text indent font size font family time roman decision making style margin margin bottom text indent font size font family time roman within subcommittee action taken each subcommittee shall taken only following unanimous vote with representative each party collectively having nbsp vote subcommittee fails reach unanimous agreement matter before period excess matter shall referred resolution style margin margin bottom text indent font size font family time roman referral dispute resolution officer resolve matter specifically delegated dispute referred subcommittee matter specifically delegated such subcommittee within after begin discussing such delegated matter applicable subcommittee referral such dispute applicable then shall escalate such matter dispute dispute resolution officer resolution such dispute resolution officer shall good faith effort resolve promptly such matter dispute which good faith effort shall include least nbsp person meeting between such dispute resolution officer such matter dispute been resolved within after submission such matter dispute such dispute resolution officer dispute resolution officer unable mutually agree resolution such matter dispute within after submission such matter dispute them including during person meeting described immediately preceding sentence then matter shall resolved accordance with section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman final decision making authority dispute resolution officer unable mutually agree within resolution matter submitted them pursuant section nbsp then company novartis shall have final decision making authority dispute related matter respectively forth below style margin margin bottom text indent font size font family time roman shall have final decision making authority dispute style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman shall have final decision making authority dispute matter relating style margin margin bottom text indent font size font family time roman notwithstanding anything contrary herein style margin margin bottom font size font family time roman each party seek right remedy available with respect matter finally resolved pursuant foregoing style margin margin bottom text indent font size font family time roman alliance manager style margin margin bottom text indent font size font family time roman appointment within following effective date each party will appoint notify other party identity senior representative such party having general understanding pharmaceutical development commercialization issue alliance manager under this agreement each alliance manager each party replace alliance manager time written notice other party style margin margin bottom text indent font size font family time roman specific responsibility alliance manager will serve primary contact point between party collaboration purpose providing each party with information progress development commercialization each collaboration product shall have following responsibility style margin margin bottom text indent font size font family time roman facilitating flow information otherwise promoting communication coordination collaboration between party style margin margin bottom text indent font size font family time roman coordinating various functional representative each party appropriate developing executing strategy plan applicable collaboration product style margin margin bottom text indent font size font family time roman providing single point communication seeking consensus both internally within respective party organization between party regarding strategy planning issue style margin margin bottom text indent font size font family time roman assisting integration team across functional area style margin margin bottom text indent font size font family time roman assisting subcommittee identifying raising cross party cross functional dispute timely manner style margin margin bottom text indent font size font family time roman performing such other function directed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman general authority conduct party each subcommittee alliance manager shall have solely power expressly assigned them this article elsewhere this agreement neither subcommittee alliance manager shall have power amend modify waive compliance with this agreement conducting themselves subcommittee alliance manager exercising their right under this article representative both party shall consider diligently reasonably good faith input received from other party shall reasonable effort reach unanimity where required matter before them style margin margin bottom text indent font size font family time roman operational separation operational separation elected pursuant section nbsp under circumstance provided therein responsibility jrdc with respect collaboration molecule collaboration product shall limited activity with respect such collaboration molecule collaboration product provided however that jrdc will still have responsibility approving annual development research plan budget avoidance doubt operational separation shall with respect collaboration whole collaboration product collaboration product collaboration molecule collaboration molecule basis notwithstanding operational separation each party continue perform nonclinical study other preclinical research with respect collaboration molecule collaboration product without coordination through jrdc style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center development style margin margin bottom text indent font size font family time roman joint development style margin margin bottom text indent font size font family time roman general party intend agree collaborate with another with respect development collaboration product field provided this article under direction jrdc pursuant respective development research program throughout territory conducting development activity provided hereunder including prosecuting regulatory approval each party shall endeavor good faith maximize economic value collaboration product party party respective responsibility with respect each collaboration product early research will forth detailed written development research plan that agreed party each development research plan further within following effective date party shall develop mutually agree upon overarching plan research development activity they contemplated undertaken under agreement including discovery research development collaboration product well research involving company technology field during least year period following effective date overall development research plan during term long fixed royalty territory encompass entire territory nbsp party shall periodically update extend renew such overall development research plan during term nbsp consistent with overall development research plan section nbsp applicable party shall provide jrdc review jrdc approval accordance with article development research plan each collaboration product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman nbsp development research plan each collaboration product shall updated from time time upon review jrdc approval accordance with article nbsp each development research plan update thereto shall nbsp reflect application commercially reasonable effort develop applicable collaboration product nbsp specify reasonable detail material development activity nbsp generate preclinical clinical regulatory other information required filing regulatory approval application such collaboration product nbsp achieve regulatory approval such collaboration product territory nbsp include those obligation assigned each party with respect performance development activity contemplated such development research plan provided however that neither development research plan overall development research plan shall assign obligation party without prior written consent such party such prior written consent lack thereof overruled final decision making authority party herein nbsp event inconsistency between development research plan this agreement term this agreement shall prevail development research plan collaboration product contemplates that collaboration product developed multiple indication then party will agree good faith which party will responsible decision making each such indication subject final decision making authority party forth section nbsp event then style margin margin bottom text indent font size font family time roman approve annual development research plan budget jrdc shall responsible preparing submitting approval detailed budget relating activity forth applicable development research plan each calendar year broken down calendar quarter covered applicable development research plan such budget amended from time time annual development research plan budget each party shall commercially reasonable effort manage development activity allocated such party applicable development research plan such that development cost associated with such development activity exceed applicable budgeted amount such activity applicable annual development research plan budget style margin margin bottom text indent font size font family time roman amendment development research plan annual development research plan budget from time time jrdc shall deem appropriate jrdc shall prepare amendment then current development research plan applicable collaboration product approval each such amended development research plan shall reflect change prioritization study within reallocation resource with respect addition then current development research plan such collaboration product addition jrdc shall prepare annual update annual development research plan budget such collaboration product without necessarily having amend corresponding development research plan later than september nbsp each calendar year order reflect change such budget following calendar year recommend such amendment approval each such amended annual development research plan budget shall specify with reasonable detail budget item described applicable development research plan once approved each amended development research plan annual style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman development research plan budget shall become effective applicable period date approved such other date shall specify approved amended development research plan annual development research plan budget shall supersede previous development research plan annual development research plan budget applicable period style margin margin bottom text indent font size font family time roman development proposal either party desire undertake development territory collaboration product research involving company technology field then such party applicable propose such development activity submitting other party jrdc written summary proposed protocol such development activity jrdc shall consider good faith take into account implement where possible reasonable comment made other party with respect such development activity party through decision making process including final decision making forth article shall decide whether undertake such development activity extent such other alternative development activity duly approved undertaken then jrdc shall prepare amendment applicable development research plan annual development research plan budget approval upon approval each party shall undertake such approved development party shall report progress such development each meeting jrdc style margin margin bottom text indent font size font family time roman responsibility development cost subject adjustment pursuant section nbsp party shall share development cost throughout territory with novartis being responsible sixty percent nbsp development cost company being responsible thirty eight percent nbsp development cost each collaboration molecule each collaboration product early research collectively such percentage sharing development cost development cost sharing percentage calculation development cost sharing percentage forth exhibit style margin margin bottom text indent font size font family time roman collaboration product company election style margin margin bottom text indent font size font family time roman collaboration product election promptly following party shall schedule special meeting jrdc date such meeting draft during jrdc meeting draft party shall collaboratively select designate additional collaboration molecule retained candidate become collaboration product under this agreement with respect which neither party their affiliate shall undertake activity outside field following designation such collaboration molecule retained candidate become collaboration product under this agreement during jrdc meeting draft party shall alternate turn selecting other collaboration molecule their development outside field with each party selecting such collaboration molecule then allowing other party select such collaboration molecule alternating turn until each party selected total such collaboration molecule their respective development outside field total such collaboration molecule development outside field party provided however that nbsp novartis select collaboration molecule that fall within covered style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman company patent company know nbsp company select collaboration molecule that fall within covered novartis patent novartis know such selection collaboration molecule company shall first beginning alternating round selection event party decline choose unable choose additional collaboration molecule before selected collaboration molecule then other party continue select collaboration molecule from after draft each party affiliate shall permitted develop commercialize such lesser number selected such party such collaboration molecule selected development outside field without further obligation reporting other party collaboration molecule selected development outside field party shall collectively referred selected molecule hereunder selected molecule shall longer considered collaboration molecule purpose hereunder avoidance doubt nothing this section nbsp shall prevent either party from style margin margin bottom text indent font size font family time roman antagonist acknowledged that company existing sting antagonist development program neither party granting hereunder right sting antagonist including part patent right know licensed party hereunder nevertheless nbsp party develop sting antagonist course activity under this agreement which sting antagonist shall part collaboration provided that they covered party patent right included within party know each case that part collaboration nbsp either party choose sole discretion grant collaboration right develop commercialize otherwise exploit sting antagonist under this agreement term agreed good faith party clarity party shall free develop commercialize otherwise exploit with third party with mean purpose without obligation reporting other party antagonist that part collaboration style margin margin bottom text indent font size font family time roman combination regimen event jrdc express interest developing product owned controlled party combination lead party such product potential combination product identified either party labeling combination with collaboration product combination regimen combination lead party agrees develop combination regimen part collaboration each party shall periodically review other product asset product opportunity that appropriate combination with collaboration product would reflected targeted labelled indication style margin margin bottom text indent font size font family time roman company election collaboration product collaboration product basis with respect individual region combination nbsp region three nbsp region profit share territory company make time election either nbsp reduce fifty percent nbsp company development cost sharing percentage development activity other than early research commercial sharing percentage collaboration product reduction profit share territory outside nbsp reduce zero company development cost sharing percentage development activity other than early research commercial sharing percentage collaboration product amended cost sharing percentage order permit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman company exercise such election shall deliver company written notice that forth anticipated commencement date commencement date least prior commencement date election notice company elect reduce eliminate sharing development cost contemplated this section nbsp delivering written notice such election prior date that later month after delivery election notice year prior commencement date company make such election with respect more such region collaboration product style margin margin bottom text indent font size font family time roman party shall promptly calculate adjust development cost sharing percentage applicable development cost development activity other than early research such collaboration product accordance with exhibit taking into consideration such election which amended cost sharing percentage shall apply with respect past future development cost such collaboration product from after january nbsp first calendar year following such election shall apply other collaboration product which shall remain unaffected such election style margin margin bottom text indent font size font family time roman from after following such election company shall credited with difference development cost sharing amount change development cost sharing percentage total development cost shared such collaboration product million company paid million since effective date such collaboration product based development cost sharing percentage applicable amended cost sharing percentage then credit would million million nbsp there remains region within profit share territory such collaboration product such credit shall applied future payment development cost shared such region nbsp there remaining region within profit share territory such collaboration product fixed royalty territory such collaboration product worldwide then amount such credit shall instead paid company novartis fully satisfied through such payment payable style margin margin bottom text indent font size font family time roman from after following such election continuing throughout remainder term commercial sharing percentage shall adjusted reducing half zero specific region applicable such collaboration product provided such reduction elimination shall apply other collaboration product which shall remain unaffected such election style margin margin bottom text indent font size font family time roman company make election reduce zero company development cost sharing percentage commercial sharing percentage collaboration product with respect more such region then immediately from after such election continuing throughout remainder term definition profit share territory shall hereby amended eliminate such region entirely applicable from such definition such region shall included fixed royalty territory each case only applicable such collaboration product shall apply other collaboration product which shall remain unaffected such election style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman company made such election with respect collaboration product included combination regimen then reduction described this section nbsp shall made addition reduction described section nbsp respect such collaboration product style margin margin bottom text indent font size font family time roman company make election reduce zero development cost sharing percentage commercial sharing percentage collaboration product with respect region then immediately from after such election continuing throughout remainder term certain other right obligation party forth under this agreement shall effected such election including forth section style margin margin bottom text indent font size font family time roman option indication expanded label during term long fixed royalty territory encompass entire territory nbsp collaboration product collaboration product basis either party time prior date that elect cease participation development payment share development more indication expanded label existing collaboration product except extent that such party becomes obligated development reimbursement payment upon commencement applicable pivotal study development such collaboration product that been subject such cessation sharing development contemplated section nbsp nbsp notwithstanding foregoing party that been allocated responsibility development activity with respect such development shall continue undertake complete such development activity unless sole remaining paying party elect cease activity such development which case party shall both promptly appropriately unwind cease such development jrdc shall accordingly amend applicable development research plan applicable annual development research plan budget nbsp with respect development that continues undertaken party party shall report progress such development activity each meeting jrdc nbsp subject immediately following sentence upon commencement applicable pivotal study applicable collaboration product indication expanded label existing collaboration product profit share territory then party that elected share cost such development activity shall other party pursuant section nbsp amount equal such amount development reimbursement payment clarity style margin margin bottom text indent font size font family time roman calculation payment development cost during term long fixed royalty territory encompass entire territory nbsp with respect each collaboration product each party will keep accurate record development cost including appropriately allocating such development cost development activity early research other development activity fixed royalty territory profit share territory applicable pursuant section nbsp nbsp beginning with first calendar quarter after effective date each party shall report other party within after style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman such calendar quarter report development cost development activity incurred such calendar quarter each such final report development cost report nbsp each development cost report shall include progress report actual versus budgeted development cost allocated incurred applicable party during applicable calendar quarter forecast remaining budgeted development cost expected incurred remaining calendar quarter respective calendar year nbsp promptly following exchange development cost report later than after relevant calendar quarter party shall reconcile amount determine amount party will need other party result sharing development cost proportion described section nbsp development cost calculation report nbsp party owed such amount forth development cost calculation report shall paid pursuant section nbsp nbsp following effective date each party shall consider good faith other reasonable procedure proposed other party sharing financial information order permit each party close book periodically timely manner nbsp addition request either party other party shall provide supporting documentation development cost incurred reported development cost report style margin margin bottom text indent font size font family time roman diligence standard conduct each party shall commercially reasonable effort perform obligation with respect development collaboration product including regulatory matter forth applicable development research plan each party shall conduct such activity including regulatory matter good scientific manner compliance with applicable each party agrees that each clinical study each nonclinical study with respect collaboration product that required posted pursuant applicable applicable industry code including phrma code equivalent industry code practice clinicaltrials other similar registry shall posted unless otherwise agreed upon party permitted applicable applicable industry code novartis shall responsible such posting collaboration product course development collaboration product neither party shall employee agent independent contractor been debarred excluded from participation government healthcare program regulatory authority best such party knowledge subject debarment exclusion proceeding regulatory authority been convicted pursuant nbsp style margin margin bottom text indent font size font family time roman development record report inspection style margin margin bottom text indent font size font family time roman each party shall maintain complete accurate record form technical notebook electronic file where appropriate work conducted under each development research program know resulting from such work such record shall fully properly reflect work done data generated result achieved performance each development research program sufficient detail good scientific manner appropriate patent regulatory purpose each party shall have right receive copy such record maintained other party including electronic format maintained such format reasonable time extent reasonably necessary style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman perform such party obligation exercise right under this agreement obtain access original extent needed patent regulatory purpose addition each party shall make available other party such other information about development research program activity including development activity prior effective date reasonably requested other party from time time purpose performing obligation exercising right under this agreement style margin margin bottom text indent font size font family time roman each party shall ensure that other party authorized representative during regular business hour more than once calendar year nbsp examine inspect such party affiliate their respective subcontractor facility used performance development activity pursuant applicable development research plan nbsp subject applicable inspect data documentation work product relating activity performed affiliate their respective subcontractor each case generated pursuant development research plan provided that event that party have right permit other party directly conduct inspection subcontractor under subsection nbsp nbsp above such party shall reasonable effort obtain such right such party unable obtain such right such party agrees upon other party request conduct such inspection other party behalf this right inspect facility data documentation work product relating collaboration product exercised time upon advance written notice each party shall responsible cost incurred with regard inspection conducted pursuant this section nbsp which cost shall considered development cost style margin margin bottom text indent font size font family time roman development subcontractor either party subcontract development activity hereunder more third party provided that nbsp subcontracting party remains responsible work allocated payment such subcontractor same extent would done such work itself including performing applicable development activity accordance with requirement timeline budget forth applicable development research plan nbsp subcontractor undertakes writing comply with obligation forth section nbsp style margin margin bottom text indent font size font family time roman material transfer style margin margin bottom text indent font size font family time roman facilitate activity contemplated this agreement either party referred this section nbsp transferring party provide other party referred this section nbsp material receiving party certain biological material chemical compound vivo model cell based assay research tool owned licensed transferring party such material compound provided hereunder referred collectively material material receiving party transfer such material transferring party material receiving party shall documented writing transfer record which transfer record shall forth type name material transferred amount material transferred date transfer such material purpose which such material used material receiving party purpose such purpose furtherance activity contemplated this agreement each case only such activity licensed subject restrictive style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman covenant under this agreement alternatively such purpose narrower restriction obligation imposed third party such material party also agree impose more restrictive material transferred between another than necessary comply with such restriction obligation imposed third party such material style margin margin bottom text indent font size font family time roman except otherwise provided under this agreement such material delivered transferring party material receiving party shall remain sole property transferring party shall only used material receiving party purpose material receiving party shall cause material used delivered used benefit third party without prior written consent transferring party provided that without limiting foregoing company transfer otherwise provide third party collaboration molecule collaboration product without obtaining prior written consent further material receiving party shall material research testing involving human subject unless expressly agreed transferring party writing where such research testing undertaken accordance with applicable addition transfer material hereunder human subject only done manner compliant with duly executed quality agreement between party style margin margin bottom text indent font size font family time roman other than forth section license granted between party including respect material their style margin margin bottom text indent font size font family time roman material receiving party assumes liability loss which arise from storage disposal material transferring party shall liable material receiving party loss claim made material receiving party made against material receiving party third party arising from material except when caused gross negligence willful misconduct transferring party otherwise expressly provided under this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center regulatory matter style margin margin bottom text indent font size font family time roman overview development research plan each collaboration product shall forth regulatory strategy seeking regulatory approval such collaboration product style margin margin bottom text indent font size font family time roman ownership regulatory filing regulatory approval right reference regulatory filing regulatory approval with respect that relate collaboration product shall filed held name company provided that other than forth previous sentence regulatory filing regulatory approval that relate collaboration product shall filed held name novartis party holding particular regulatory filing regulatory approval jurisdiction shall referred herein lead regulatory party respect such regulatory filing regulatory approval such jurisdiction applicable lead regulatory party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman regulatory meeting correspondence style margin margin bottom text indent font size font family time roman generally cost applicable lead regulatory party shall responsible interfacing corresponding meeting with regulatory authority jurisdiction with respect collaboration product unless otherwise stipulated herein cost interfacing corresponding meeting with regulatory authority profit share territory shall shared between party development cost except travel expense which lead regulatory party shall absorb incurs such expense cost interfacing corresponding meeting with regulatory authority throughout fixed royalty territory shall paid novartis development cost except travel expense which novartis shall absorb incurs such expense style margin margin bottom text indent font size font family time roman conduct regulatory activity style margin margin bottom text indent font size font family time roman applicable lead regulatory party shall responsible nbsp submitting regulatory filing including application regulatory approval relating collaboration molecule collaboration product nbsp leading nbsp scheduled face face meeting video conference teleconference with applicable regulatory authority nbsp preparatory meeting such meeting with applicable regulatory authority other party shall have right have nbsp senior experienced employee reasonably acceptable applicable lead regulatory party participate extent practicable observer such face face meeting video conference teleconference preparatory meeting applicable lead regulatory party shall provide other party copy nbsp material documentation prepared such meeting nbsp material submission applicable regulatory authority relating development process obtaining regulatory approval applicable collaboration product each case extent practicable sufficiently advance applicable meeting submission applicable allow such other party reasonable opportunity review provide comment such material such applicable lead regulatory party shall consider good faith such other party comment with respect thereto style margin margin bottom text indent font size font family time roman applicable lead regulatory party delegate other party such responsibility interfacing corresponding meeting with applicable regulatory authority with respect collaboration product mutually agreed upon party style margin margin bottom text indent font size font family time roman collaboration product withdrawal recall nbsp regulatory authority threatens initiate advises action remove collaboration product from market requires advises party their respective affiliate sublicensees distributor distribute dear doctor letter equivalent regarding such collaboration product nbsp either party determines that event incident circumstance occurred that result need recall market withdrawal collaboration style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman product distribution dear doctor letter equivalent regarding such collaboration product then each case nbsp nbsp company novartis applicable shall notify other party such event determination immediately event within twenty four nbsp hour sooner required applicable after such party becomes aware event make such determination applicable lead regulatory party applicable jurisdiction shall extent practicable endeavor discus agree with other party upon whether recall withdraw collaboration product question provided however that such discussion practicable party fail agree within appropriate time period recognizing exigency situation then such applicable lead regulatory party shall decide whether recall withdraw such collaboration product applicable jurisdiction style margin margin bottom text indent font size font family time roman pharmacovigilance agreement within following effective date soon reasonably practicable following such period party shall enter into written pharmacovigilance agreement governing each party respective obligation with respect allocation responsibility reporting other party appropriate regulatory authority adverse event complaint other safety related matter style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center commercialization style margin margin bottom text indent font size font family time roman overview diligence party intend agree collaborate with another with respect commercialization collaboration product field territory provided this article under direction novartis shall commercially reasonable effort commercialize collaboration product novartis promotion territory after receipt regulatory approval therefor long included fixed royalty territory company shall commercially reasonable effort commercialize collaboration product after receipt regulatory approval therefor conducting commercialization activity provided hereunder including setting price other commercial term collaboration product each party shall endeavor good faith maximize economic value collaboration product party style margin margin bottom text indent font size font family time roman commercialization style margin margin bottom text indent font size font family time roman long company elected under section nbsp reduce company development cost sharing percentage with respect company shall commercial lead from after novartis shall commercial lead time during term novartis shall commercial lead throughout territory outside commercial lead with respect territory outside respectively shall referred herein lead commercialization party such jurisdiction applicable lead commercialization party style margin margin bottom text indent font size font family time roman applicable lead commercialization party shall implement have sole authority responsibility commercialization collaboration product territory outside each case accordance with applicable commercialization plan term this agreement applicable lead commercialization party shall book monies style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman received selling party from third party customer sale collaboration product business decision regarding commercialization collaboration product territory outside shall within sole discretion applicable lead commercialization party material used promotion collaboration product territory outside including product packaging material used detailing doctor product messaging content used promotion such collaboration product shall within sole discretion applicable lead commercialization party applicable lead commercialization party shall permit other party through representative provide advice commentary with respect commercialization activity performed behalf applicable lead commercialization party other party applicable lead commercialization party shall good faith consider such advice commentary such other party shall cooperate assist with applicable lead commercialization party commercialization activity reasonable request such applicable lead commercialization party style margin margin bottom text indent font size font family time roman least prior anticipated first commercial sale collaboration product territory outside applicable lead commercialization party shall submit comprehensive plan each commercialization plan that describes launch launch subsequent commercialization such collaboration product territory outside applicable including anticipated activity relating messaging branding pricing advertising planning marketing sale force training allocation distribution strategy implementing those activity associated budget such activity applicable lead commercialization party shall permit other party through representative provide advice commentary such commercialization plan applicable lead commercialization party shall good faith consider such advice commentary annual basis more often party deem appropriate applicable lead commercialization party shall prepare amendment then current applicable commercialization plan shall submit such amendment review comment other party applicable lead commercialization party shall required obtain approval applicable commercialization plan amendment thereto prior implementation provided however that applicable lead commercialization party allocate responsibility commercialization activity other party commercialization plan amendment thereof unless such allocation been approved such other party style margin margin bottom text indent font size font family time roman global branding strategy each collaboration product shall develop thereafter update from time time each case with approval global branding strategy including global positioning global brand element such collaboration product field territory each global branding strategy novartis shall commercially reasonable effort implement global branding strategy commercialization collaboration product novartis promotion territory long included fixed royalty territory company shall commercially reasonable effort implement global branding strategy commercialization collaboration product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercialization cost style margin margin bottom text indent font size font family time roman allocation commercialization cost fixed royalty territory novartis shall responsible hundred percent nbsp commercialization cost incurred with respect each collaboration product fixed royalty territory style margin margin bottom text indent font size font family time roman allocation commercialization cost profit share territory during term long fixed royalty territory encompass entire territory novartis company shall responsible their respective commercial sharing percentage collaboration cost incurred party with respect applicable region profit share territory each collaboration product style margin margin bottom text indent font size font family time roman calculation payment commercialization cost with respect each collaboration product each party will keep accurate record commercialization cost including appropriately allocating such commercialization cost fixed royalty territory profit share territory applicable pursuant section beginning with first calendar quarter after effective date each party shall report other party within after such calendar quarter report commercialization cost associated activity applicable region profit share territory incurred such calendar quarter such commercialization cost each such report commercialization cost report provided that commercialization cost report shall also include those commercialization cost incurred party period beginning effective date ending immediately before first first full calendar quarter term each commercialization cost report shall include progress report actual versus budgeted commercialization cost allocated incurred applicable party during applicable calendar quarter forecast remaining budgeted commercialization cost expected incurred remaining calendar quarter respective calendar year promptly following exchange commercialization cost report later than after relevant calendar quarter novartis shall submit company report reconciling calculation amount party will need other party result sharing commercialization cost proportion described section nbsp applicable commercialization cost calculation report party owed such amount forth commercialization cost calculation report shall paid pursuant section nbsp that each company novartis borne respective share commercialization cost forth hereunder following effective date each party shall consider good faith other reasonable procedure proposed other party sharing financial information order permit each party close book periodically timely manner addition request either party other party shall provide supporting documentation commercialization cost incurred reported commercialization cost report style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman diligence standard conduct each party shall commercially reasonable effort perform obligation with respect commercialization collaboration product including regulatory matter forth applicable commercialization plan course commercialization collaboration product neither party shall employee agent independent contractor been debarred excluded from participation government healthcare program regulatory authority best such party knowledge subject debarment exclusion proceeding regulatory authority been convicted pursuant nbsp style margin margin bottom text indent font size font family time roman commercialization subcontractor novartis subcontract commercialization activity hereunder more third party long included fixed royalty territory company subcontract activity directed hereunder more third party further company after obtaining prior consent novartis unreasonably withheld subcontract over such activity more third party provided that each case nbsp subcontracting party remains responsible work allocated payment such subcontractor same extent would done such work itself including performing applicable commercialization activity accordance with requirement timeline budget forth applicable commercialization plan nbsp subcontractor undertakes writing comply with obligation forth section nbsp addition with respect material subcontracting commercialization activity company agrees consider good faith capability availability cost using novartis subcontractor such activity provided that decision party used will company sole discretion style margin margin bottom text indent font size font family time roman reporting each party shall keep fully informed regarding progress result such party commercialization activity each collaboration product throughout territory including providing their respective quarterly result annual review result versus goal each party shall reasonably cooperate good faith provide assistance other party order translate financial information result from accounting standard other reasonably necessary order facilitate satisfy each party external reporting obligation objective style margin margin bottom text indent font size font family time roman commercialization standard conduct style margin margin bottom text indent font size font family time roman each party shall shall cause affiliate subcontractor distributor respect comply with applicable developing commercializing collaboration product field territory including extent applicable foreign corrupt practice amended fcpa bribery chapter amended bribery public health service amended prescription drug marketing amended federal health care program anti kickback nbsp amended health insurance portability accountability amended guidance industry supported scientific educational activity federal state local fraud style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman abuse consumer protection false claim statute regulation including medicare state health program anti fraud abuse amendment social security safe harbor regulation found nbsp office inspector general compliance guidance program pharmaceutical research manufacturer america code interaction with healthcare professional hereafter amended from time time standard forth accreditation council continuing medical education relating educating medical community territory nbsp implementing regulation also known national physician payment transparency program open payment program sunshine foreign statutory statutory equivalent territory foregoing provided that with respect sunshine each party shall responsible reporting payment other transfer value actually made such party each party shall commercially reasonable effort cooperate with other party coordinate such disclosure each party represents warrant other party that effective date such party affiliate have adequate procedure place support their compliance with fcpa bribery territory each party affiliate nbsp shall maintain such procedure throughout term shall promptly notify other party writing with respect material compliance with applicable regarding development commercialization collaboration product field territory style margin margin bottom text indent font size font family time roman each party affiliate shall shall commercially reasonable effort cause subcontractor distributor directly indirectly promote market collaboration product nbsp country territory which such person authorized promote market under authorized promote market pursuant this agreement nbsp indication approved applicable regulatory authority such country style margin margin bottom text indent font size font family time roman each party shall shall cause affiliate subcontractor distributor ensure that their sale representative promoting collaboration product nbsp have skill training experience generally consistent with industry standard applicable country territory applicable promotion marketing sale prescription pharmaceutical product such country nbsp have satisfactorily completed collaboration product specific training ethic compliance training required such party style margin margin bottom text indent font size font family time roman each party shall shall cause affiliate subcontractor distributor their respective sale representative nbsp make statement representation warranty oral written concerning collaboration product country territory labeling literature promotional marketing material collaboration product country territory that nbsp contrary inconsistent with regulatory approval such collaboration product such country manner that violates applicable such country nbsp violates applicable such country nbsp make arrangement with make payment provide gift other incentive healthcare professional violation applicable such country each party shall shall cause affiliate subcontractor distributor ensure that their sale style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman representative familiar with procedure obligation right responsibility imposed term this agreement applicable performance promotional activity hereunder each party shall shall cause affiliate subcontractor distributor maintain record their sale representative activity style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center manufacture supply style margin margin bottom text indent font size font family time roman overview party shall responsible manufacture supply each collaboration product development commercialization throughout responsible supply collaboration product development commercialization throughout style margin margin bottom text indent font size font family time roman development manufacturing process certain clinical supply subject section nbsp with respect each collaboration product shall lead development manufacturing process such each collaboration product consultation with reasonable actual cost manufacturing process development scale shall shared development cost novartis company shall agree upon manufacturing chain clinical supply that meet relevant regulatory requirement guideline ensures that each party supply sufficient development style margin margin bottom text indent font size font family time roman commercial supply agreement during term long fixed royalty territory encompass entire territory least year prior anticipated filing each collaboration product least party will enter into commercially reasonable mutually agreeable commercial supply agreement pursuant which nbsp novartis would supply such collaboration product mark negotiated with such mark ultimately netted share profit nbsp supply collaboration product shall allocated throughout profit share territory fair equitable manner nbsp company would permitted establish qualify maintain second source supply anticipated requirement collaboration product with cost therefor shared commercialization cost nbsp company would permitted obtain supply from second source event supply shortage supply failure style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center grant right style margin margin bottom text indent font size font family time roman right granted novartis style margin margin bottom text indent font size font family time roman development subject term condition this agreement during term company hereby grant novartis affiliate exclusive with company affiliate licensable only pursuant section nbsp right territory under company patent company know solely undertake development activity collaboration product field limited extent contemplated authorized pursuant this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercialization subject term condition this agreement long included fixed royalty territory during term company hereby grant novartis affiliate exclusive licensable only pursuant section nbsp right under company patent company know solely provide support requested company connection with commercialization collaboration product field pursuant section nbsp only extent contemplated authorized company prior writing pursuant this agreement style margin margin bottom text indent font size font family time roman commercialization novartis promotion territory subject term condition this agreement during term company hereby grant novartis affiliate exclusive even company affiliate licensable only pursuant section nbsp right novartis promotion territory under company patent company know solely commercialize collaboration product field novartis promotion territory extent contemplated authorized pursuant this agreement style margin margin bottom text indent font size font family time roman manufacture subject term condition this agreement company hereby grant novartis affiliate exclusive with company affiliate licensable only pursuant section right territory under company patent company know solely undertake manufacturing activity collaboration product field extent contemplated authorized pursuant this agreement other written agreement party style margin margin bottom text indent font size font family time roman right further license subject term condition this agreement each party license right granted other party under this agreement such party affiliate respective subcontractor distributor other service provider providing assistance such party affiliate their development manufacturing commercialization collaboration product benefit party extent contemplated authorized pursuant this agreement other licensing such right granted party under this agreement shall undertaken without consent other party style margin margin bottom text indent font size font family time roman right granted company style margin margin bottom text indent font size font family time roman development subjec term condition this agreement during term novartis hereby grant company affiliate exclusive with novartis affiliate licensable only pursuant section nbsp right territory under novartis patent novartis know solely undertake development activity collaboration product field limited extent contemplated authorized pursuant this agreement style margin margin bottom text indent font size font family time roman commercialization subject term condition this agreement long included fixed royalty territory during term novartis hereby grant company affiliate exclusive with novartis affiliate licensable only pursuant section nbsp right under novartis patent novartis know solely commercialize collaboration product field extent contemplated authorized pursuant this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman manufacture subject term condition this agreement novartis hereby grant company affiliate exclusive with novartis affiliate licensable only pursuant section right territory under novartis patent novartis know solely undertake manufacturing activity collaboration product field extent contemplated authorized pursuant this agreement other written agreement party style margin margin bottom text indent font size font family time roman right further license subject term condition this agreement company license right granted novartis under this agreement company affiliate respective subcontractor distributor other service provider providing assistance company affiliate their development collaboration product benefit party extent contemplated authorized pursuant this agreement other licensing such right granted novartis under this agreement shall undertaken without consent novartis style margin margin bottom text indent font size font family time roman implied license except explicitly forth this agreement neither party grant other party license express implied under patent right know other intellectual property right controlled such party style margin margin bottom text indent font size font family time roman retained right style margin margin bottom text indent font size font family time roman notwithstanding anything that construed contrary herein company retains right company technology order develop commercialize otherwise exploit product service field throughout world other than collaboration product field never same product with same formulation collaboration product avoidance doubt without prejudice right granted herein novartis license right granted this agreement novartis develop commercialize product product platform technology owned controlled company including that sting agonist style margin margin bottom text indent font size font family time roman notwithstanding anything that construed contrary herein novartis retains right novartis technology order develop commercialize otherwise exploit product service field throughout world other than collaboration product field never same product with same formulation collaboration product avoidance doubt without prejudice right granted herein company license right granted this agreement company develop commercialize product product platform technology owned controlled novartis including that sting agonist style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center financial term style margin margin bottom text indent font size font family time roman upfront consideration license right granted novartis hereunder novartis shall company time refundable creditable upfront payment hundred million dollar million within business after effective date style margin margin bottom text indent font size font family time roman milestone payment further consideration license other right granted novartis upon achievement each milestone event each milestone forth table immediately below novartis shall corresponding time milestone payment each milestone payment company style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom font size font family time roman milestone style margin margin bottom border bottom solid width font size font family time roman number valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone nbsp event valign bottom nbsp valign bottom align center style border bottom solid milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom nowrap nbsp nbsp table style margin margin bottom text indent font size font family time roman clarification style margin margin bottom text indent font size font family time roman milestone number each achieved become payable only once nbsp milestone number achieved become payable three nbsp time total style margin margin bottom text indent font size font family time roman milestone number achieved then effective upon achievement milestone number even only once applicable then milestone number shall also payable even though missing milestone number been achieved nbsp milestone number achieved then effective upon achievement milestone number even only once applicable then milestone number shall also payable even though missing milestone number been achieved nbsp milestone number achieved then effective upon achievement milestone number even only once applicable then milestone number shall also payable even though missing milestone number been achieved nbsp extent milestone number achieved three nbsp time then effective upon achievement milestone number applicable then milestone number shall also payable taken together with past achievement milestone number having been achieved nbsp avoidance doubt achievement milestone number shall itself trigger payment previous style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman milestone shall only trigger payment milestone payment that corresponds milestone number nbsp event will total payment made accordance with this section nbsp nbsp total more than million style margin margin bottom text indent font size font family time roman payment made novartis accordance with section shall once they paid refundable creditable style margin margin bottom text indent font size font family time roman milestone payment after achievement milestone company shall send notice such achievement writing novartis submit invoice novartis form separately confirmed between party with respect corresponding milestone payment unless otherwise disputed novartis good faith accordance with section nbsp novartis shall company such milestone payment within after receipt such invoice style margin margin bottom text indent font size font family time roman royalty payment fixed royalty territory style margin margin bottom text indent font size font family time roman fixed royalty territory during applicable royalty term further consideration right granted company novartis hereunder following first commercial sale collaboration product country fixed royalty territory throughout remainder applicable royalty term subject reduction provided under section nbsp novartis shall make royalty payment company equal amount sale such collaboration product such country within fixed royalty territory each calendar year provided however after later nbsp date expiration lapse invalidation last valid claim whether such valid claim valid claim under company patent novartis patent joint patent covering such collaboration product such country nbsp expiration data exclusivity conferred competent regulatory authority such collaboration product such country continuing throughout remainder royalty term royalty payment hereunder shall reduced from what otherwise would payable novartis company under this agreement further upon expiration royalty term collaboration product country fixed royalty territory license granted novartis under this agreement with respect such collaboration product such country shall become fully paid royalty free license which shall continue even after termination this agreement style margin margin bottom text indent font size font family time roman clarification style margin margin bottom text indent font size font family time roman payment made novartis accordance with this section nbsp shall once they paid refundable creditable reason whatsoever including limited termination this agreement reason reason style margin margin bottom text indent font size font family time roman royalty will payable collaboration product collaboration product country country basis within fixed royalty territory during applicable royalty term royalty shall payable only once with respect sale same unit collaboration product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman sale royalty report within after each calendar quarter during term following first commercial sale collaboration product country fixed royalty territory novartis will provide company sale nbsp royalty report nbsp company shall paid royalty indicated sale nbsp royalty report pursuant section nbsp style margin margin bottom text indent font size font family time roman profit share payment following first commercial sale collaboration product profit share territory throughout remainder term such collaboration product each party lead commercialization party shall entitled receive their respective commercial sharing percentage gross profit sale such collaboration product profit share territory applicable each region within profit share territory give effect foregoing style margin margin bottom text indent font size font family time roman within after each calendar quarter following such first commercial sale lead commercialization party shall report other party sale such collaboration product each profit share territory made behalf such party including providing other party with sale nbsp profit share report their respective sale collaboration product each profit share territory style margin margin bottom text indent font size font family time roman following receipt such information party shall reconcile calculate determine what payment made between party give effect appropriate allocation gross profit contemplated under this section nbsp party paid shall paid pursuant section style margin margin bottom text indent font size font family time roman third party obligation style margin margin bottom text indent font size font family time roman existing third party license novartis company shall mutually agreed time execute separate sublicenses existing third party license based form forth exhibit acceptable both party nbsp company shall duly when amount under each existing third party license nbsp extent existing third party license requires payment based development commercialization collaboration product excluding existing third party licensor shared existing third party payment which attributable collaboration product profit share territory globally such amount shall collaboration product first commercial sale anywhere territory development cost collaboration product first commercial sale anywhere territory case except extent such amount payable solely relate fixed royalty territory nbsp further respect payment made company under existing third party license solely fixed royalty territory novartis affiliate shall reimburse company such payment amount equal such term used defined applicable existing third party agreement fixed royalty territory such reimbursed amount novartis existing fixed royalty territory payment such paid quarterly same schedule nbsp avoidance doubt company shall solely responsible shall hold harmless novartis affiliate from against obligation liability existing third party license shall included commercialization cost development cost otherwise required shared between party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman third party license style margin margin bottom text indent font size font family time roman event that determines after reasonable discussion consultation between party that patent right other intellectual property right owned controlled third party other than patent right other intellectual property right that addressed existing third party license should licensed acquired order develop manufacture commercialize collaboration product anywhere territory third party license with goal party treating such right manner similar possible that joint patent joint know novartis affiliate shall enter into agreement with such third party secure such patent right other intellectual property right cost obtaining such right shall shared party under this agreement follows nbsp amount payable such third party novartis affiliate obtain exercise such right shall collaboration product first commercial sale anywhere territory development cost collaboration product first commercial sale anywhere territory case except extent such amount payable solely relate fixed royalty territory nbsp royalty payment payable such third party that solely relate fixed royalty territory novartis fixed royalty territory payment shall shared through royalty deduction mechanism below section style margin margin bottom text indent font size font family time roman novartis elect designate intellectual property later acquired novartis technology then cost obtaining such right shall shared party under this agreement follows amount payable such third party novartis affiliate obtain exercise such right shall collaboration product first commercial sale anywhere territory development cost collaboration product first commercial sale anywhere territory case except extent such amount payable solely relate fixed royalty territory nbsp none royalty payment payable such third party that solely relate fixed royalty territory shall paid company which shall paid novartis style margin margin bottom text indent font size font family time roman company elect designate intellectual property later acquired company technology then cost obtaining such right shall shared party under this agreement follows amount payable such third party company affiliate obtain exercise such right shall collaboration product first commercial sale anywhere territory development cost collaboration product first commercial sale anywhere territory case except extent such amount payable solely relate fixed royalty territory nbsp none royalty payment payable such third party that solely relate fixed royalty territory shall paid novartis which shall paid company style margin margin bottom text indent font size font family time roman royalty deduction novartis reduce royalty payment company sale given collaboration product given calendar year style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman amount plus long royalty payment from novartis company than aggregate amount sale each collaboration product within fixed royalty territory such calendar year nbsp portion amount such payment entitled deducted novartis from royalty deducted reason operation limitation forth last proviso preceding sentence such portion will carried over deducted against subsequent royalty payment until full amount that novartis would have been entitled deduct operation such limitation deducted style margin margin bottom text indent font size font family time roman form payment currency notwithstanding anything contrary amount paid under this agreement calendar quarter during term other than milestone payment upfront payment under section nbsp collectively payment shall paid follows nbsp payment related development cost sharing section commercial cost sharing section profit share payment section fixed royalty territory royalty section nbsp well pertinent royalty deduction section will reconciled party within following each calendar quarter establish amount paid party payor other party payee respect satisfaction such payment between party that became payable such calendar quarter promptly thereafter payee shall invoice payor such amount that paid payor nbsp within payor receipt such invoice from payee payor shall remit such payment payee nbsp avoidance doubt nbsp extent either party dispute payment portion thereof then undisputed portion such payment shall still paid pursuant foregoing provision nbsp milestone payment shall paid accordance with when they become payable payment from party other party shall made wire transfer immediately available fund dollar credit such bank account designated other party this agreement writing such party payment which fall date which business made next succeeding business when conversion payment from foreign currency required undertaken party nbsp dollar equivalent shall calculated using such party then current standard exchange rate conversion methodology applied external reporting which shall accordance with applicable accounting standard style margin margin bottom text indent font size font family time roman late payment party receive payment within date therefor simple interest shall thereafter accrue daily basis such party from date until date payment annum rate libor plus maximum rate allowable applicable whichever style margin margin bottom text indent font size font family time roman each party will provide timely accurate documentation other party upon request that shall enable party determine payment subject withholding entitled reduced withholding under existing income treaty each party will levied account payment made under this agreement required withheld party such party will nbsp deduct such from payment made other party nbsp timely proper taxing authority nbsp send proof payment party nbsp reasonably assist other party effort style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman obtain credit such payment each party agrees reasonably assist other party lawfully claiming exemption from minimizing such deduction withholding under double taxation similar circumstance before effective date company shall provide novartis complete accurate properly executed internal revenue service form other applicable form style margin margin bottom text indent font size font family time roman record audit right style margin margin bottom text indent font size font family time roman financial record each party shall keep complete accurate book record with respect activity undertaken pursuant this agreement accordance with accounting standard sufficient detail support calculation payment that become hereunder each party will keep such book record longer nbsp following calendar year which they pertain nbsp expiry applicable statute limitation style margin margin bottom text indent font size font family time roman audit style margin margin bottom text indent font size font family time roman each party shall have right appoint internationally recognized independent certified public accounting firm which reasonably acceptable other party auditor audit relevant book record other party correctness payment made required made other party pursuant term this agreement before beginning audit auditor shall execute undertaking reasonably acceptable other party which auditor shall keep confidential information reviewed during such audit auditor shall have right disclose auditing party only conclusion regarding payment owed under this agreement style margin margin bottom text indent font size font family time roman audited party shall make book record available inspection such auditor during regular business hour such place place where such book record customarily kept upon receipt reasonable advance notice from other party solely verify accuracy payment made hereunder auditor only audit book record audited party from prior calendar year which audit request made such inspection right shall exercised more than once calendar year more frequently than once with respect book record covering specific period time information received information learned party course audit inspection shall constitute confidential information other party style margin margin bottom text indent font size font family time roman auditing party shall cost auditor well expense associated with enforcing right with respect payment hereunder except that event there upward adjustment aggregate amount payable calendar year shown such audit more than amount paid audited party shall cost auditor style margin margin bottom text indent font size font family time roman after conducting audit pursuant this section nbsp auditor concludes that additional payment were hereunder then audited party shall make such make such additional payment other party pursuant section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman projection company novartis acknowledge agree that nothing this agreement shall construed representing estimate projection anticipated sale collaboration product that milestone sale gross profit level forth above elsewhere this agreement that have otherwise been discussed party merely intended define milestone payment royalty obligation event such milestone sale level achieved neither party make representation warranty either express implied that either party will able successfully develop commercialize collaboration product commercialized that particular milestone sale level gross profit level such collaboration product will achieved style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property style margin margin bottom text indent font size font family time roman ownership existing invention between party company shall company patent company know existing effective date novartis affiliate shall novartis patent novartis know existing effective date style margin margin bottom text indent font size font family time roman disclosure invention inventorship determination each party shall promptly disclose other party invention discovery that conceived discovered otherwise made behalf such party course conducting activity under this agreement whether patentable joint invention each case including invention disclosure other similar document submitted such party affiliate subcontractor sublicensees director officer employee representative agent describing such invention applicable disclosed invention each party shall take step with respect filing patent other form intellectual property protection such disclosed invention before inventorship such disclosed invention determined intellectual property counsel each party through good faith consultation event dispute inventorship such disclosed invention party shall submit dispute independent intellectual property counsel mutually agreed upon party whose decision inventorship shall considered final style margin margin bottom text indent font size font family time roman ownership program invention each party shall equal undivided interest invention discovery that conceived discovered otherwise made reduced practice behalf either both party their respective affiliate subcontractor sublicensees their respective director officer employee representative agent course performing activity under this agreement whether patentable collectively joint invention patent right arising therefrom collectively such patent right with respect joint invention joint patent know that conceived discovered otherwise made course performing activity under this agreement behalf either both party their respective affiliate subcontractor sublicensees their respective director officer employee representative agent course performing activity under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman collectively joint know other intellectual property right thereto each case extent such joint invention joint patent joint know disclosed company patent novartis patent each party shall have full right license assign exploit such joint invention joint patent arising therefrom anywhere world without requirement gaining consent accounting other party subject license granted herein subject section nbsp implied license inventorship shall determined accordance with united state federal patent purpose clarification ownership regulatory filing regulatory approval shall governed section nbsp style margin margin bottom text indent font size font family time roman filing prosecution maintenance defense company patent style margin margin bottom text indent font size font family time roman company shall have initial right responsibility filing prosecuting maintaining enforcing defending patent application patent related company patent sole cost with commercially reasonable diligence company shall provide novartis with timely copy material communication from applicable patent office concerning prosecution company patent provide novartis opportunity reasonably advance filing deadline comment thereon consult with company about consider good faith request suggestion novartis concerning such prosecution style margin margin bottom text indent font size font family time roman least prior applicable date national stage filing international patent application filed under patent cooperation treaty that would company patent company shall provide novartis with list country region into which company intends file such national stage application this list shall include minimum each which filed either directly through such international patent application novartis request that company file such national stage application more additional country except provided herein company shall retain sole right responsibility prosecuting maintaining defending patent application patent related company patent style margin margin bottom text indent font size font family time roman either party learns actual suspected commercially material infringement third party patent related company patent shall promptly notify other party representative novartis company shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp provided that company shall initially controlling party such action style margin margin bottom text indent font size font family time roman upon notice that third party commenced action oppose revoke cancel invalidate patent related company patent novartis company shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp provided that company shall initially controlling party such action style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman event that company decides with respect country file prosecute abandon lapse patent application patent related company patent during term company shall notify novartis such decision least prior expiration deadline relating such activity novartis shall have option obligation assume responsibility writing within such notice prosecuting maintaining defending such patent application patent novartis sole expense failure provide such written notice shall considered decision other party that will exercise such option such option shall immediately terminate assuming novartis exercise option novartis shall keep company informed material communication from applicable patent office concerning prosecution such patent application patent style margin margin bottom text indent font size font family time roman filing prosecution maintenance defense novartis patent style margin margin bottom text indent font size font family time roman novartis shall have initial right responsibility filing prosecuting maintaining enforcing defending patent application patent related novartis patent sole cost with commercially reasonable diligence novartis shall provide company with timely copy material communication from applicable patent office concerning prosecution novartis patent provide company opportunity reasonably advance filing deadline comment thereon consult with novartis about consider good faith request suggestion company concerning such prosecution style margin margin bottom text indent font size font family time roman least prior applicable date national stage filing international patent application filed under patent cooperation treaty that would novartis patent novartis shall provide company with list country region into which novartis intends file such national stage application this list shall include minimum each which filed either directly through such international patent application company request that novartis file such national stage application more additional country except provided herein novartis shall retain sole right responsibility prosecuting maintaining defending patent application patent related novartis patent style margin margin bottom text indent font size font family time roman either party learns actual suspected commercially material infringement third party patent related novartis patent shall promptly notify other party representative company novartis shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp provided that novartis shall initially controlling party such action style margin margin bottom text indent font size font family time roman upon notice that third party commenced action oppose revoke cancel invalidate patent related novartis patent company novartis shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp provided that novartis shall initially controlling party such action style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman event that novartis decides with respect country file prosecute abandon lapse patent application patent related novartis patent during term novartis shall notify company such decision least prior expiration deadline relating such activity company shall have option obligation assume responsibility writing within such notice prosecuting maintaining defending such patent application patent company sole expense failure provide such written notice shall considered decision other party that will exercise such option such option shall immediately terminate assuming company exercise option company shall keep novartis informed material communication from applicable patent office concerning prosecution such patent application patent style margin margin bottom text indent font size font family time roman filing prosecution maintenance defense joint invention style margin margin bottom text indent font size font family time roman joint patent style margin margin bottom text indent font size font family time roman shall provide nbsp reasonable opportunity review comment such filing prosecution maintenance effort regarding such joint patent territory reasonably prior submission with applicable patent authority nbsp with copy material communication from patent authority jurisdiction territory regarding such joint patent shall provide draft material filing material response made such patent authority reasonable amount time advance submitting such filing response that have opportunity review comment thereon decision regarding prosecution maintenance joint patent shall decided joint intellectual property committee cost course performing filing prosecution maintenance activity territory forth this section nbsp shall equally shared between party style margin margin bottom text indent font size font family time roman either party learns actual suspected commercially material infringement third party joint patent shall promptly notify other party representative company novartis shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp provided that style margin margin bottom text indent font size font family time roman upon notice that third party commenced action oppose revoke cancel invalidate joint patent company novartis shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp including which party shall controlling party such action pocket cost incurred party enforcing defending such infringement shall shared party accordance with their respective commercial sharing percentage based territory which such action brought style margin margin bottom text indent font size font family time roman cooperation each party shall provide other party reasonable notice assistance cooperation patent prosecution effort other party including with respect patent term extension supplemental protection certificate orange book listing other patent filing linkage including providing necessary power attorney executing other required document instrument such prosecution style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman patent term extension style margin margin bottom text indent font size font family time roman shall responsible determining strategy applying extension term patent which responsibility prosecute maintain defend under this article such under drug price competition patent term restoration hereinafter supplementary certificate protection member state european union other similar measure other country requested shall apply reasonable effort obtain such extension should require respective affiliate subcontractor sublicensees hereunder apply hereby give permission which case agrees cooperate with exercise such authorization shall execute such document take such additional action reasonably request connection therewith novartis company agree cooperate with another obtaining patent extension hereunder style margin margin bottom text indent font size font family time roman shall responsible determining strategy with respect certification notice patent enforcement procedure regarding patent which responsibility prosecute maintain defend under this article under biologics price competition innovation hereinafter bpcia shall cooperate reasonably requested manner consistent with this section nbsp hereby authorizes nbsp provide connection with bpcia list patent that include nbsp except otherwise provided this agreement exercise right exercisable patent owner under bpcia nbsp exercise right that exercisable reference product sponsor under bpcia including nbsp engaging patent resolution provision bpcia with regard patent which responsibility prosecute maintain defend under this article nbsp determining which patent will subject immediate patent infringement action under nbsp bpcia provided that with respect exercise right under bpcia shall consult with representative designated writing qualified receive confidential information pursuant nbsp bpcia with respect exercise right exercisable reference product sponsor including providing such representative with timely copy material correspondence relating such matter providing such representative opportunity reasonably advance related action comment thereon consult with consider good faith request suggestion with respect such matter style margin margin bottom text indent font size font family time roman event that desire apply extension patent which responsibility prosecute maintain defend under this article under supplementary certificate protection member state european union other similar measure other country utilize such patent purpose engaging patent resolution provision bringing patent infringement action under bpcia party shall meet good faith discus strategy such activity provided that shall obligated agree such patent such activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman enforcement defense patent right style margin margin bottom text indent font size font family time roman party asserting right enforce defend patent under this agreement controlling party shall keep other party reasonably informed during course legal action related such enforcement defense action shall consult with such other party before taking major step during conduct such action other party shall provide reasonable cooperation controlling party connection with such action including being named party such action required standing purpose style margin margin bottom text indent font size font family time roman controlling party action shall take position with respect compromise settle such action that reasonably likely directly adversely affect scope validity enforceability patent without other party prior written consent unreasonably withheld conditioned delayed style margin margin bottom text indent font size font family time roman party having right controlling party action shall provide prompt written notice other party sufficiently timely manner that such action will prejudiced style margin margin bottom text indent font size font family time roman intend pursue action pursuant this section nbsp take such other action required permitted under bpcia preserve ability prosecute potential action style margin margin bottom text indent font size font family time roman commenced such action within earlier nbsp after notice infringement nbsp prior time limit forth under applicable filing such action taking such other action style margin margin bottom text indent font size font family time roman ceased intends cease diligently pursue such action such other action style margin margin bottom text indent font size font family time roman upon receipt such written notice under section nbsp other party shall have option become controlling party other party shall respond with written notice within indicating intends exercise such option upon which such other party shall become controlling party take action expense enforce take such other action with respect such action including initiating action taking over prosecution such action initiated previously failure provide such written notice shall considered decision other party that will exercise such option such option shall immediately terminate style margin margin bottom text indent font size font family time roman recovery from action shall first used offset expense each party directly attributable such action proportion each party expense remaining recovery shall belong controlling party provided that such remaining recovery belonging novartis shall treated sale novartis shall company royalty thereon accordance with royalty rate forth herein style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman manufacture development commercialization collaboration product result claim threatened claim third party against party patent infringement other violation intellectual property right party first having notice thereof shall promptly notify other writing notice shall forth fact claim reasonable detail shall have initial right obligation controlling party such claim style margin margin bottom text indent font size font family time roman personnel obligation prior beginning work under this agreement relating development manufacture commercialization collaboration molecule collaboration product each employee subcontractor consultant representative agent novartis company either party respective affiliate sublicensees shall bound disclosure invention assignment obligation which consistent with obligation novartis company applicable this article extent permitted applicable including nbsp promptly reporting novartis company applicable invention discovery process other intellectual property right nbsp assigning novartis company applicable right title interest invention discovery process other intellectual property right nbsp taking action reasonably necessary secure patent other intellectual property protection such invention discovery process other intellectual property right nbsp performing signing executing acknowledging delivering document required effecting obligation purpose this agreement nbsp abiding obligation confidentiality forth article understood agreed that such disclosure invention assignment agreement need reference specific this agreement style margin margin bottom text indent font size font family time roman trademark style margin margin bottom text indent font size font family time roman corporate trademark logo each party affiliate shall retain right title interest their respective corporate trademark house mark corporate name logo neither party shall without other party prior written consent such trademark house mark corporate name logo other party mark confusingly similar thereto connection with such party commercialization collaboration product under this agreement provided that with regard each collaboration product extent legally permissible company will include novartis logo relevant trademark packaging material regarding such collaboration product style margin margin bottom text indent font size font family time roman mark company after reasonable consultation with novartis shall responsible selection trademark mark connection with sale marketing such collaboration product territory field provided that unless party mutually agree otherwise such mark shall contain name novartis another trademark owned controlled novartis company shall responsible registration maintenance defense such mark shall such mark trademark cost incurred connection therewith mark applicable collaboration style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman product territory shall determined trademark cost shall shared equally mark shall comply with applicable including those regulation particularly applying proper designation trademark style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty style margin margin bottom text indent font size font family time roman mutual representation warranty each party hereby represents warrant other party execution date follows style margin margin bottom text indent font size font family time roman corporate existence power corporation duly organized validly existing good standing under jurisdiction which incorporated full corporate power authority legal right operate property asset carry business being conducted contemplated this agreement including right grant license granted hereunder style margin margin bottom text indent font size font family time roman authority binding agreement nbsp corporate power authority legal right enter into this agreement perform obligation hereunder nbsp taken necessary corporate action part required authorize execution delivery this agreement performance obligation hereunder nbsp this agreement been duly executed delivered behalf such party constitutes legal valid binding obligation such party that enforceable against accordance with term subject application principle equity availability remedy specific performance applicable public policy court discretion style margin margin bottom text indent font size font family time roman conflict party agreement commitment that would prevent from granting right granted intended granted other party under this agreement performing obligation under this agreement style margin margin bottom text indent font size font family time roman debarment neither such party affiliate thereof debarred been convicted subject debarment conviction pursuant nbsp style margin margin bottom text indent font size font family time roman representation warranty covenant company except forth company disclosure schedule company hereby represents warrant novartis execution date with respect section nbsp only covenant during term follows with respect each collaboration product collaboration molecule applicable style margin margin bottom text indent font size font family time roman exhibit attached hereto forth complete accurate list company patent existence execution date including owner owner thereof style margin margin bottom text indent font size font family time roman exhibit attached hereto forth complete accurate list license assignment distribution other agreement relating company patent true complete correct copy such agreement amended prior execution date have been provided novartis prior execution date style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman company owns control company patent company know free from encumbrance listed record appropriate governmental authority owner record licensee each registration grant application included company patent company know style margin margin bottom text indent font size font family time roman company nbsp with respect patent right know owned obtained from individual participated respect invention authorship patent right know effective assignment ownership right such individual such patent right know nbsp knowledge with respect patent right know licensed licensors under existing third party license have obtained from individual participated respect invention authorship patent right know effective assignment ownership right such individual such patent right know with respect nbsp nbsp extent that such patent right know would constitute company patent company know applicable controlled company either pursuant written agreement operation style margin margin bottom text indent font size font family time roman affiliate employee officer subcontractor consultant have executed agreement have existing obligation under applicable requiring assignment company affiliate applicable invention made during course result their association with company obligating individual maintain confidential company confidential information well confidential information other party including novartis affiliate which such individual receive extent required support company obligation under this agreement style margin margin bottom text indent font size font family time roman knowledge company company right grant novartis right under company patent company know that purport grant hereunder style margin margin bottom text indent font size font family time roman application registration maintenance renewal respect company patent execution date have been with respect company patent owned company company knowledge with respect company patent licensed company paid necessary document certificate have been filed with relevant agency purpose maintaining company patent style margin margin bottom text indent font size font family time roman company knowledge development manufacture commercialization collaboration molecule collaboration product infringe patent right misappropriate know third party company received written notice alleging such infringement misappropriation style margin margin bottom text indent font size font family time roman there agreement arrangement which company affiliate party relating collaboration product collaboration molecule company patent company know that would limit right granted novartis under this agreement that restrict will result restriction party ability develop manufacture commercialize collaboration molecule collaboration product field territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman neither company affiliate their respective officer employee representative agent made untrue statement material fact fraudulent statement other regulatory authority with respect development collaboration molecule collaboration product failed disclose material fact required disclosed other regulatory authority with respect development collaboration molecule collaboration product committed made statement failed make statement with respect development collaboration molecule collaboration product that could reasonably expected provide basis invoke policy respecting fraud untrue statement material fact bribery illegal gratuity forth september amendment thereto style margin margin bottom text indent font size font family time roman course development collaboration product neither company affiliate used prior execution date employee agent independent contractor been debarred excluded from participation government healthcare program regulatory authority company knowledge subject debarment exclusion proceeding regulatory authority been convicted pursuant nbsp style margin margin bottom text indent font size font family time roman existing third party license full force effect modified amended prior execution date company provided novartis accurate copy such existing third party license redacted portion thereof material novartis decision enter into assert right perform obligation under this agreement neither company company knowledge third party licensor default with respect material obligation under neither such party claimed company knowledge ground upon which claim that other party default with respect material obligation under existing third party license except identified exhibit company control other third party intellectual property necessary novartis practice license right granted under this agreement style margin margin bottom text indent font size font family time roman company shall during term with respect each existing third party license nbsp maintain full force effect such existing third party license nbsp promptly provide novartis with party notice default under such existing third party license nbsp extent within company reasonable control take action fail take action allow event occur that would give respective existing third party licensor right terminate such existing third party license without written consent novartis nbsp amend modify such existing third party license manner that will adversely affect novartis right under this agreement without novartis prior written consent nbsp exercise right itself terminate waive material right under which waiver would adversely affect novartis right under this agreement such existing third party license without prior written consent novartis nbsp extent practicable notify novartis prior termination such existing third party license addition company shall promptly provide novartis with copy amendment existing third party license made after effective date third party granted company license patent right know that controlled company affiliate that would controlled company affiliate within definition company patent right company know style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman representation warranty novartis novartis hereby represents warrant company execution date follows with respect each collaboration product collaboration molecule applicable style margin margin bottom text indent font size font family time roman exhibit attached hereto forth complete accurate list novartis patent existence execution date including owner owner thereof style margin margin bottom text indent font size font family time roman exhibit attached hereto forth list sting agonist included within novartis know execution date style margin margin bottom text indent font size font family time roman exhibit attached hereto forth complete accurate list license assignment distribution other agreement relating novartis patent true complete correct copy such agreement have been provided company prior execution date style margin margin bottom text indent font size font family time roman novartis owns control novartis patent novartis know free from encumbrance listed record appropriate governmental authority owner record licensee each registration grant application included novartis patent novartis know style margin margin bottom text indent font size font family time roman knowledge novartis novartis with respect patent right know owned knowledge with respect patent right know licensed obtained from individual participated respect invention authorship patent right know effective assignment ownership right such individual such patent right know extent that such patent right know would constitute novartis patent novartis know applicable controlled novartis either pursuant written agreement operation style margin margin bottom text indent font size font family time roman affiliate employee officer subcontractor consultant have executed agreement have existing obligation under applicable requiring assignment novartis affiliate applicable invention made during course result their association with novartis obligating individual maintain confidential novartis confidential information well confidential information other party including novartis affiliate which such individual receive extent required support company obligation under this agreement style margin margin bottom text indent font size font family time roman knowledge novartis novartis right grant company license under novartis patent novartis know that purport grant hereunder style margin margin bottom text indent font size font family time roman application registration maintenance renewal respect novartis patent execution date have been with respect novartis patent owned style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman novartis novartis knowledge with respect novartis patent licensed novartis paid necessary document certificate have been filed with relevant agency purpose maintaining novartis patent style margin margin bottom text indent font size font family time roman novartis knowledge development manufacture commercialization collaboration molecule collaboration product infringe patent right misappropriate know third party novartis received written notice alleging such infringement misappropriation style margin margin bottom text indent font size font family time roman there agreement arrangement which novartis affiliate party relating collaboration product collaboration molecule novartis patent novartis know that would limit right granted company under this agreement that restrict will result restriction party ability develop manufacture commercialize collaboration molecule collaboration product field territory style margin margin bottom text indent font size font family time roman neither novartis affiliate their respective officer employee representative agent made untrue statement material fact fraudulent statement other regulatory authority with respect development collaboration molecule collaboration product failed disclose material fact required disclosed other regulatory authority with respect development collaboration molecule collaboration product committed made statement failed make statement with respect development collaboration molecule collaboration product that could reasonably expected provide basis invoke policy respecting fraud untrue statement material fact bribery illegal gratuity forth september amendment thereto style margin margin bottom text indent font size font family time roman course development collaboration product neither novartis affiliate used prior effective date employee agent independent contractor been debarred regulatory authority novartis knowledge subject debarment proceeding regulatory authority been convicted pursuant nbsp style margin margin bottom text indent font size font family time roman novartis control other third party intellectual property necessary company practice license right granted under this agreement third party granted novartis license patent right know that controlled novartis affiliate that would controlled novartis affiliate within definition novartis technology style margin margin bottom text indent font size font family time roman restriction technology style margin margin bottom text indent font size font family time roman transfer title company covenant agrees that from execution date until expiration term neither affiliate shall enter into agreement with third party whether written oral with respect otherwise assign transfer license convey right title interest grant other encumbrance style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman under company technology collaboration product each case that would prevent from granting right novartis company under this agreement that would restrict either party ability develop manufacture commercialize such molecule such collaboration product field territory accordance with this agreement style margin margin bottom text indent font size font family time roman existing third party agreement during term company affiliate novartis affiliate shall take action omit take action that would result material breach early termination existing third party license material right thereunder each party shall promptly notify other party after receipt notice actual alleged breach under existing third party license that could result termination such agreement material reduction other material limitation right thereunder breaching party shall entitled cure such breach loss incurred doing against payment under this agreement style margin margin bottom text indent font size font family time roman other representation warranty except expressly stated this agreement representation warranty whatsoever whether express implied including warranty merchantability fitness particular purpose infringement made given behalf party except expressly stated this agreement representation warranty whether arising operation otherwise hereby expressly excluded style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification style margin margin bottom text indent font size font family time roman indemnification company subject other provision this article company shall defend novartis affiliate sublicensees each their respective officer director agent representative employee collectively novartis indemnitees from against charge allegation notice civil criminal administrative claim demand complaint cause action proceeding investigation third party collectively claim indemnify hold harmless such novartis indemnitees from against loss liability obligation award settlement penalty fine sanction damage reasonable cost including award court cost reasonable attorney collectively loss that result from such claim where extent that such claim made brought against novartis indemnitee behalf third party solely extent such claim based arises style margin margin bottom text indent font size font family time roman negligent reckless willful action omission company affiliate performing company obligation under this agreement other agreement entered into connection with this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman breach obligation covenant warranty representation made company under this agreement other agreement entered into connection with this agreement style margin margin bottom text indent font size font family time roman development manufacture collaboration molecule collaboration product behalf company affiliate licensee prior effective date style margin margin bottom text indent font size font family time roman misappropriation trade secret proprietary material patentable subject matter each case owned controlled third party relation development manufacture collaboration product collaboration molecule company sting technology time prior effective date whether behalf company affiliate from which company affiliate benefited style margin margin bottom text indent font size font family time roman with respect patent right know licensed under existing third party license failure obtain effective assignment ownership right such patent right know respective existing third party licensor style margin margin bottom text indent font size font family time roman violation applicable company affiliate licensee course activity under this agreement style margin margin bottom text indent font size font family time roman company breach existing third party license whether prior after effective date style margin margin bottom font size font family time roman provided however except each case extent that such claim loss attributable matter which novartis obligated indemnify company indemnitee pursuant section nbsp below style margin margin bottom text indent font size font family time roman indemnification novartis subject other provision this article novartis shall defend company affiliate sublicensees each their respective officer director agent representative employee collectively company indemnitees from against claim indemnify hold harmless such company indemnitees from against loss that result from such claim where extent that such claim made brought against company indemnitee behalf third party solely extent such claim based arises style margin margin bottom text indent font size font family time roman negligent reckless willful action omission novartis affiliate performing novartis obligation under this agreement other agreement entered into connection with this agreement style margin margin bottom text indent font size font family time roman breach obligation covenant warranty representation made novartis under this agreement other agreement entered into connection with this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman development manufacture collaboration molecule collaboration product behalf novartis affiliate licensee prior effective date style margin margin bottom text indent font size font family time roman misappropriation trade secret proprietary material patentable subject matter each case owned controlled third party relation development manufacture collaboration product collaboration molecule time prior effective date whether behalf novartis affiliate from which novartis affiliate benefited style margin margin bottom text indent font size font family time roman violation applicable novartis affiliate licensee course activity under this agreement style margin margin bottom font size font family time roman provided however except each case extent that such claim loss attributable matter which company obligated indemnify novartis indemnitee pursuant section nbsp above style margin margin bottom text indent font size font family time roman indemnification procedure person entitled indemnification pursuant either section nbsp section nbsp will hereinafter referred indemnitee party obligated indemnify indemnitee hereunder will hereinafter referred indemnitor event novartis indemnitee company indemnitee seeking indemnification under either section nbsp section nbsp novartis company applicable will inform applicable indemnitor claim soon reasonably practicable event more than after receives notice claim being understood agreed that failure give notice claim provided this section nbsp will relieve indemnitor indemnification obligation under this agreement except only extent that such indemnitor actually materially prejudiced result such failure give notice indemnitee will permit indemnitor assume direction control defense such claim using counsel selected indemnitor reasonably acceptable indemnitee indemnitor expense will cooperate cause affiliate agent cooperate reasonably requested defense such claim indemnitee will have right retain counsel expense provided that indemnitor assumes control such defense indemnitee reasonably concludes based advice from counsel that indemnitor indemnitee have conflicting interest with respect such claim indemnitor will responsible cost counsel indemnitee other indemnitees connection with same claim multiple claim arising same event circumstance indemnitor settle such claim otherwise consent adverse judgment such claim without indemnitee prior written consent unreasonably withheld delayed provided that indemnitor shall required obtain such consent with respect settlement claim under which sole relief provided monetary damage that paid full indemnitor which would diminish limit otherwise adversely affect right activity financial interest indemnitee which result finding admission fault indemnitee each indemnitee indemnitor shall make admission liability respect claim without prior written consent other party indemnitee shall reasonable effort mitigate loss arising from such claim style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman defense indemnification product liability claim except claim covered section nbsp with respect shared product liability claim during term party agree that style margin margin bottom text indent font size font family time roman each company novartis shall indemnify hold harmless novartis indemnitees company indemnitees applicable from against respective commercial sharing percentage based territory which such shared product liability claim brought loss incurred such novartis indemnitees company indemnitees applicable based arising shared product liability claim made brought against novartis indemnitees company indemnitees applicable behalf third party product liability share style margin margin bottom text indent font size font family time roman either party becomes aware shared product liability claim shall inform other party soon reasonably practicable event more than after receives notice such shared product liability claim being understood agreed that failure either party give notice shared product liability claim will relieve other party obligation under this agreement except only extent that such other party actually materially prejudiced result such failure give notice style margin margin bottom text indent font size font family time roman novartis shall assume direction control defense shared product liability claim company will cooperate reasonably requested defense such shared product liability claim provided that novartis shall nbsp counsel reasonably acceptable company provided further that company reasonably concludes based advice from counsel that company novartis have conflicting interest with respect such shared product liability claim company shall have right obtain counsel cost nbsp keep company reasonably informed status such defense nbsp consult with company good faith with regard material litigation strategy decision connection with such defense including applicable joining company party novartis shall provide company invoice company product liability share cost such defense each calendar quarter during term unless otherwise disputed company good faith accordance with section nbsp company shall amount forth such invoice novartis within after receipt style margin margin bottom text indent font size font family time roman novartis settle compromise shared product liability claim without obtaining consent company such consent unreasonably withheld delayed style margin margin bottom text indent font size font family time roman each calendar quarter during term each party shall provide other party with full accounting loss incurred connection with shared product liability claim which each party obligated indemnify other pursuant subsection nbsp above together with invoice such loss pursuant section nbsp unless otherwise disputed other party good faith such other party shall amount forth invoice within after receipt such invoice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman novartis shall indemnify hold harmless company indemnitees from against loss incurred such company indemnitees based arising novartis product liability claim made brought against company indemnitees behalf third party style margin margin bottom text indent font size font family time roman limitation liability neither party affiliate shall liable equity contract tort negligence breach statutory duty otherwise special indirect incidental punitive consequential damage loss profit opportunity diminution goodwill suffered other party affiliate except extent such damage required paid third party result claim which party provides indemnification under this article nbsp notwithstanding anything express implied this section nbsp party affiliate applicable shall entitled recover amount accrued owing under this agreement style margin margin bottom text indent font size font family time roman insurance each party shall procure maintain insurance which take form self insurance including product liability insurance with respect activity hereunder which consistent with normal business practice prudent company similarly situated time during which collaboration product being clinically tested human subject commercially distributed sold understood that such insurance shall construed create limit either party liability with respect indemnification obligation under this article each party shall provide other party with written evidence such insurance upon request each party shall provide other party with written notice least prior cancellation renewal material change such insurance self insurance which materially adversely affect right other party hereunder style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center confidentiality style margin margin bottom text indent font size font family time roman duty confidence style margin margin bottom text indent font size font family time roman subject other provision this article confidential information disclosed party disclosing party affiliate under this agreement will maintained confidence otherwise safeguarded other party recipient party recipient party only confidential information purpose this agreement pursuant right granted recipient party under this agreement subject other provision this article each party shall hold confidential such confidential information other party affiliate same manner with same protection such recipient party maintains confidential information subject style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman other provision this article recipient party only disclose confidential information other party employee representative agent sublicensees subcontractor consultant adviser recipient party affiliate extent reasonably necessary purpose those matter undertaken pursuant this agreement provided that such person bound maintain confidentiality confidential information manner consistent with confidentiality provision this agreement style margin margin bottom text indent font size font family time roman subject other provision this article existence this agreement term condition this agreement shall considered confidential information both party each party shall maintain confidence otherwise safeguard such term condition such accordance with this article style margin margin bottom text indent font size font family time roman exception obligation under this article shall apply information extent recipient party demonstrate competent evidence that such information style margin margin bottom text indent font size font family time roman time disclosure becomes after time disclosure known public part public domain through breach this agreement recipient party affiliate style margin margin bottom text indent font size font family time roman known otherwise possession recipient party affiliate prior time disclosure disclosing party affiliate style margin margin bottom text indent font size font family time roman disclosed recipient party affiliate confidential basis third party entitled disclose without breaching confidentiality obligation disclosing party affiliate style margin margin bottom text indent font size font family time roman independently developed behalf recipient party affiliate evidenced written record without reference confidential information disclosed disclosing party affiliate under this agreement style margin margin bottom font size font family time roman specific aspect detail confidential information shall deemed within public domain possession recipient party merely because confidential information embraced more general information public domain possession recipient party further combination confidential information shall considered public domain possession recipient party merely because individual element such confidential information public domain possession recipient party unless combination principle public domain possession recipient party style margin margin bottom text indent font size font family time roman authorized disclosure style margin margin bottom text indent font size font family time roman addition disclosure allowed under section nbsp each party disclose confidential information belonging other party affiliate solely extent such disclosure necessary following instance nbsp filing prosecuting patent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman right permitted this agreement nbsp connection with regulatory filing product nbsp prosecuting defending litigation permitted this agreement nbsp complying with applicable court order governmental regulation including rule self regulatory organization filing disclosure requirement nbsp company disclosure confidential information under this agreement including novartis confidential information existing third party licensor limited extent required existing third party license nbsp extent such disclosure reasonably necessary with prior notice possible under circumstance nbsp comply with term agreement with third party related collaboration product that exist effective date nbsp comply with term agreement with third party related collaboration product that entered into after effective date provided that such agreement entered into compliance with term this agreement further provided that provision such agreement requiring disclosure other party confidential information have been reviewed approved such other party such approval unreasonably withheld nbsp potential actual investor acquirer necessary connection with their evaluation potential actual investment acquisition provided that such person shall subject obligation confidentiality least protective those forth this article viii nbsp extent otherwise necessary appropriate connection with right performing obligation hereunder style margin margin bottom text indent font size font family time roman event recipient party required disclose confidential information disclosing party applicable court order governmental regulation connection with bona fide legal process such disclosure shall breach this agreement provided that recipient party nbsp informs disclosing party soon reasonably practicable required disclosure nbsp limit disclosure that which legally required disclosed nbsp disclosing party request expense assist attempt object limit required disclosure style margin margin bottom text indent font size font family time roman either party disclose existence term this agreement confidence attorney advisor potential acquirer their respective professional attorney advisor connection with potential merger acquisition reorganization existing potential investor lender such party part their diligence investigation existing potential licensee sublicensees permitted assignee each case under agreement keep term confidentiality substantially rigorous than term contained this agreement such information solely purpose permitted pursuant this section nbsp style margin margin bottom text indent font size font family time roman public disclosure data style margin margin bottom text indent font size font family time roman neither party affiliate shall except required applicable reasonable judgment such party affiliate their counsel publicly disclose data result clinical study nonclinical study that have already been publicly disclosed with respect collaboration molecule collaboration product whether conducted prior during term except provided this section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman scientific medical conference presentation data result clinical study nonclinical study relating arising development activity hereunder scientific medical conference shall mutual written agreement party style margin margin bottom text indent font size font family time roman publication publication data result clinical study nonclinical study relating arising development activity hereunder peer reviewed journal publication shall made only pursuant this section nbsp party proposing publication shall provide other party with opportunity review proposed publication least business prior intended submission publication other party offer comment publication submitting party submit publication business after provided publication reviewing party earlier with written consent reviewing party submitting party shall consider comment reviewing party good faith party unable agree upon aspect publication including form content timing including with respect additional time required seeking patent protection invention disclosed publication proposed medium publication either party refer dispute which shall resolve dispute best interest development commercialization collaboration molecule collaboration product manner designed extent possible enable each party comply with publication policy submitting party shall provide other party copy publication time submission notwithstanding foregoing shall have right authorize publication either party confidential information without such party consent except that this restriction shall restrict from authorizing publication clinical study result each party agrees acknowledge contribution other party employee other party publication scientifically appropriate style margin margin bottom text indent font size font family time roman publicity style margin margin bottom text indent font size font family time roman press release relating this agreement will mutually agreed upon party shall released effective date unless otherwise agreed party neither party shall issue other press release make other public announcement concerning this agreement term hereof collaboration without prior written consent other party which consent shall unreasonably withheld delayed provided that event that party fails provide such prior written consent party wishing issue such press release public announcement refer such dispute resolution accordance with section nbsp party preparing such other press release public announcement shall reasonably practicable provide other party with draft thereof least business prior date which such party would like issue press release make public announcement provided however that party issue such press release public announcement without such prior review consent other party nbsp content such press release public announcement have previously been made public other than through breach this agreement issuing party nbsp such press release public announcement materially differ from previously issued press release other publicly available information notwithstanding foregoing under circumstance style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman either party name trademark trade name logo image other party affiliate publicity press release other public announcement including website public forum without prior written consent other party addition party enters into sublicense other agreement with sublicensee subcontractor other third party such party shall permit such sublicensee subcontractor other third party name trademark trade name logo image other party affiliate publicity press release other public announcement including website public forum without prior written consent other party style margin margin bottom text indent font size font family time roman notwithstanding other provision this article each party make disclosure required including disclosure term this agreement comply with duty disclosure have pursuant applicable pursuant rule governmental authority including recognized stock exchange event disclosure required applicable governmental authority rule recognized stock exchange party shall coordinate with each other with respect timing form content such required disclosure party unable agree timing form content required disclosure such disclosure shall limited minimum required reasonably determined party subject disclosure requirement consultation with legal counsel notwithstanding foregoing requested other party party subject such requirement shall commercially reasonable effort obtain order protecting maximum extent possible confidentiality required disclosure such portion thereof reasonably requested other party including provision this agreement requested other party redacted from filing with other governmental authority recognized stock exchange style margin margin bottom text indent font size font family time roman return confidential information upon expiration termination this agreement recipient party shall return disclosing party destroy confidential information received recipient party from disclosing party except copy which retained confidential file archive purpose notwithstanding return destruction disclosing party confidential information recipient party shall continue bound obligation confidentiality other obligation under this article style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom text indent font size font family time roman term term this agreement term shall become effective effective date shall remain effect subject earlier termination under section nbsp until date that later nbsp expiration royalty term throughout fixed royalty territory collaboration product nbsp date which party mutually agree cease promotion sale collaboration product throughout profit share territory fixed royalty territory comprise entire territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman termination either party breach insolvency style margin margin bottom text indent font size font family time roman breach either party breaching party without prejudice other remedy available under applicable equity terminate this agreement entirety with respect more collaboration product more country territory other party breaching party shall have materially breached nbsp representation warranty made such party under this agreement nbsp obligation under this agreement case clause nbsp such breach shall have continued case payment breach after written notice thereof provided breaching party breaching party describing alleged breach subject section nbsp such termination this agreement under this section nbsp shall become effective such cure period unless style margin margin bottom text indent font size font family time roman breaching party cured such breach prior expiration such cure period style margin margin bottom text indent font size font family time roman such breach susceptible cure within such cure period even with commercially reasonable effort which event breaching party right termination shall suspended only long nbsp breaching party provided breaching party written plan that reasonably calculated effect cure applicable breach nbsp such plan acceptable breaching party sole discretion confirmed writing nbsp breaching party commits carry such plan provided that unless otherwise mutually agreed party event shall such suspension breaching party right terminate extend beyond after original cure period style margin margin bottom text indent font size font family time roman disagreement party reasonably good faith disagree whether there been material breach party that seek dispute that there been material breach contest allegation accordance with section nbsp cure period allegation made good faith material breach under this agreement will subject section nbsp from date that written notice first provided breaching party breaching party provided that such cure period shall stayed event that during such cure period alleged breaching party shall have initiated dispute resolution good faith accordance with section nbsp with respect alleged breach which stay shall last long such alleged breaching party diligently good faith cooperates prompt resolution such dispute resolution proceeding style margin margin bottom text indent font size font family time roman insolvency either company novartis terminate this agreement entirety immediately upon written notice other party insolvency event occurs relation other party event when party first becomes aware likely occurrence insolvency event regard that party such party shall promptly notify other party sufficient time give other party sufficient notice protect such other party interest under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman termination either party safety reason either party shall have right exercisable time terminate this agreement with respect collaboration product either whole specific indication such collaboration product good faith belief that advisable party continue develop commercialize such collaboration product either whole such indication from scientific regulatory ethical perspective result bona fide serious safety issue regarding such collaboration product such indication provided that prior exercising such termination right such issue applicable party desire terminate this agreement with respect such collaboration product either whole such indication result such issue shall have been deliberated with care both jrdc style margin margin bottom text indent font size font family time roman termination novartis convenience time after third nbsp anniversary effective date novartis shall have right exercisable time terminate this agreement entirety convenience hundred eighty nbsp notice company style margin margin bottom text indent font size font family time roman effect expiration termination style margin margin bottom text indent font size font family time roman accrued obligation termination sole remedy except otherwise expressly provided herein expiration termination this agreement reason shall release either party from liability obligation that time such expiration termination already accrued other party that attributable period prior such expiration termination will termination this agreement preclude either party from pursuing right remedy have under this agreement equity with respect breach this agreement prior such expiration termination style margin margin bottom text indent font size font family time roman effect expiration termination style margin margin bottom text indent font size font family time roman upon earlier termination this agreement entirety with respect more collaboration product pursuant section nbsp more country territory upon earlier termination this agreement with respect more collaboration product pursuant section nbsp section nbsp throughout territory then with respect such collaboration product country applicable style margin margin bottom text indent font size font family time roman each license under section nbsp such collaboration product such country shall terminate style margin margin bottom text indent font size font family time roman novartis shall cease commercialization activity development activity related such collaboration product such country style margin margin bottom text indent font size font family time roman milestone achieved with respect such collaboration product after effective date termination applicable collaboration product shall give rise milestone payment novartis style margin margin bottom text indent font size font family time roman following expiration royalty term throughout fixed royalty territory collaboration product mutual agreement party cease style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman promotion sale collaboration product throughout profit share territory fixed royalty territory comprise entire territory license granted novartis under this agreement with respect such collaboration product throughout fixed royalty territory shall continue fully paid royalty free license novartis discretion without accounting other obligation company continue commercialization activity development activity related collaboration product throughout fixed royalty territory style margin margin bottom text indent font size font family time roman additional effect termination addition effect forth section nbsp upon termination this agreement entirety novartis pursuant section nbsp section nbsp party pursuant section nbsp right obligation company novartis shall forth this section nbsp purpose hereof nbsp discontinuing party shall mean nbsp novartis event termination novartis pursuant section nbsp section nbsp company pursuant section nbsp nbsp company event termination novartis pursuant section nbsp nbsp continuing party shall mean nbsp company event termination novartis pursuant section nbsp section nbsp company pursuant section nbsp nbsp novartis event termination novartis pursuant section nbsp style margin margin bottom text indent font size font family time roman effective upon date such termination discontinuing party hereby grant continuing party right license under nbsp novartis patent novartis know novartis discontinuing party nbsp company patent company know company continuing party each case have used develop have developed manufacture have manufactured commercialize have commercialized collaboration product field territory provided that neither party will obligated enter into transaction described this section nbsp neither party will have liability other failure discontinuing party hereby acknowledges agrees that continuing party shall free joint know joint patent joint invention without need accounting with respect thereto style margin margin bottom text indent font size font family time roman prior effective date such termination party shall negotiate good faith agree upon commercially reasonable transition plan that forth strategy estimated schedule transition know collaboration product continuing party order seek minimize disruption development commercialization collaboration product transition plan shall provide that party shall commercially reasonable effort support commercialization development regulatory activity such other matter party agree party shall cooperate good faith provide each other reasonable consultation assistance effect smooth orderly transition including with respect transfer responsibility ongoing clinical study style margin margin bottom text indent font size font family time roman continuing party option which shall exercised written notice extent permitted under applicable discontinuing party shall assign cause assigned continuing party designee cost style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman continuing party regulatory filing made with regulatory approval obtained from regulatory authority territory specifically relating collaboration product case only extent such assignment legally permissible extent such assignment legally permissible discontinuing party shall take reasonable action make available continuing party designee benefit such regulatory filing regulatory approval style margin margin bottom text indent font size font family time roman discontinuing party shall promptly provide continuing party cost continuing party know material other development data specifically relating collaboration product provided that discontinuing party shall entitled retain copy such item legal archival regulatory purpose discontinuing party shall nbsp deliver continuing party nbsp clinical data information discontinuing party possession control relating solely collaboration product including clarity manufacturing data nbsp copy report record regulatory correspondence other material discontinuing party possession control relating solely clinical development collaboration product each case nbsp nbsp same form which discontinuing party maintains such data information other item style margin margin bottom text indent font size font family time roman discontinuing party shall grant continuing party right reference that term defined analogous applicable recognized outside united state with respect regulatory filing development data transferred continuing party pursuant section nbsp above style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman discontinuing party shall have right continue sell existing inventory collaboration product period exceed after effective date such termination continuing party shall continue receive royalty gross profit payment with respect such sale accordance with term hereof style margin margin bottom text indent font size font family time roman viii discontinuing party shall assign continuing party right title interest mark used exclusively with collaboration product style margin margin bottom text indent font size font family time roman company discontinuing party novartis shall company amount that company obligated third party under existing third party license result license granted novartis pursuant section nbsp addition novartis shall comply with other obligation third party license that applicable grant novartis license pursuant section nbsp style margin margin bottom text indent font size font family time roman company continuing party party shall negotiate good faith supply agreement manufacture supply commercial product following effective such termination which agreement shall commercially reasonable term shall provide that upon company request time during term such agreement novartis shall transfer supply company designee such agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman shall have term that commences upon effective date such termination continues until later nbsp anniversary effective date such termination nbsp completion transition supply company designee validation successor supplier including company required continue with development commercialization activity respect collaboration product style margin margin bottom text indent font size font family time roman except forth this section nbsp section nbsp right obligation party hereunder solely with respect such collaboration product such country with respect other collaboration product country shall terminate date such termination provided that other than event termination this agreement entirety right obligation with respect remaining collaboration product country under this agreement shall continue pursuant term this agreement style margin margin bottom text indent font size font family time roman right bankruptcy style margin margin bottom text indent font size font family time roman license commercialization manufacturing development right granted under pursuant this agreement will otherwise deemed purpose nbsp united state bankruptcy code nbsp code similar other country territory license right intellectual property defined under section nbsp code party agree that novartis licensee such right under this agreement will retain fully exercise protection right election under code similar other country territory party further agree that event commencement bankruptcy proceeding against company under code similar other country territory novartis will entitled complete duplicate complete access appropriate such intellectual property embodiment such intellectual property same already possession will promptly delivered nbsp upon such commencement bankruptcy proceeding upon written request therefor unless company elect continue perform obligation under this agreement nbsp delivered under nbsp above upon written request therefor novartis following rejection this agreement behalf company style margin margin bottom text indent font size font family time roman right power remedy novartis provided this section nbsp addition substitution other right power remedy hereafter existing equity including under code similar other country territory event bankruptcy company novartis addition right power remedy expressly provided herein shall entitled exercise other such right power resort other such remedy hereafter exist equity including under code similar other country territory party agree that they intend following novartis right extend maximum extent permitted including purpose code similar other country territory nbsp right access intellectual property including embodiment thereof company third party with whom company contract perform obligation company under this agreement which style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman necessary development manufacture commercialization collaboration product territory nbsp right contract directly with third party described nbsp complete contracted work nbsp right cure breach default under such agreement with third party cost thereof against amount payable company under this agreement style margin margin bottom text indent font size font family time roman survival notwithstanding anything contrary following provision shall survive continue apply after expiration termination this agreement entirety section with respect matter relating term until third style font size vertical align nbsp anniversary expiration termination agreement article until applicable statute limitation expired article until date that year after expiration termination agreement article article expiration termination this agreement reason will affect payment obligation under this agreement with respect payment amount that have accrued date such expiration termination style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center change control style margin margin bottom text indent font size font family time roman acquisition change control style margin margin bottom text indent font size font family time roman notice event change control company company applicable successor following change control acquired party acquired party shall notify novartis such change control writing later than after effective date such change control change control notice style margin margin bottom text indent font size font family time roman election upon change control novartis elect within change control notice upon written notice company effect option described nbsp below style margin margin bottom text indent font size font family time roman continue party collaboration pursuant term this agreement style margin margin bottom text indent font size font family time roman terminate this agreement effective date specified novartis with effect described section nbsp section nbsp section nbsp style margin margin bottom text indent font size font family time roman effect operational separation with effect provided section style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman during except pursuant subject provision this agreement during term party affiliate then such party nbsp style margin margin bottom text indent font size font family time roman discretion request party shall discus nbsp following such discussion party then nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman request made pursuant section nbsp then nbsp style margin margin bottom text indent font size font family time roman such case party affiliate style margin margin bottom text indent font size font family time roman during provided however that such party style margin margin bottom text indent font size font family time roman each party acknowledges that each party acknowledges that style margin margin bottom text indent font size font family time roman intention party that style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center governing dispute resolution style margin margin bottom text indent font size font family time roman governing this agreement including claim controversy arising relating this agreement shall governed state york without regard conflict principle that would result application other than state york united nation convention contract international sale good nbsp shall apply interpretation this agreement style margin margin bottom text indent font size font family time roman dispute resolution style margin margin bottom text indent font size font family time roman unless otherwise forth this agreement including section nbsp event dispute arising under this agreement between party either party shall have right refer such dispute respective dispute resolution officer such dispute resolution officer shall attempt good faith resolve such dispute party unable resolve given dispute pursuant this section nbsp within referring such dispute dispute resolution officer such dispute shall resolved pursuant section nbsp provided that dispute that subject party final decision making authority pursuant section nbsp shall subject dispute resolution procedure section nbsp subject further dispute resolution whether court equity otherwise party expressly waive forego right trial jury style margin margin bottom text indent font size font family time roman event unresolved dispute arising under this agreement between party party final decision making authority pursuant section nbsp including such dispute that resolved under section nbsp within such dispute being referred dispute resolution officer each party reserve right remedy available under applicable equity with respect such dispute each party irrevocably submits exclusive jurisdiction united state district court southern district york purpose suit action other proceeding arising this agreement subject this section nbsp each party agrees commence such action suit proceeding united state district court southern district york such suit action other proceeding brought such court jurisdictional reason supreme court state york york county each party irrevocably unconditionally waif objection laying venue style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman such action suit proceeding arising this agreement united state district court southern district york hereby thereby further irrevocably unconditionally waif agrees plead claim such court that such action suit proceeding brought such court been brought inconvenient forum style margin margin bottom text indent font size font family time roman injunctive relief remedy breach exclusivity nothing section nbsp shall limit effect party exercise right under this section nbsp notwithstanding anything this agreement contrary party seek temporary restraining order preliminary injunction from court competent jurisdiction time order prevent immediate irreparable injury loss damage provisional basis pending resolution dispute hereunder including under this article style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement including exhibit hereto forth complete final exclusive agreement covenant promise agreement warranty representation condition understanding between party with respect subject matter hereof supersedes prior agreement understanding between party existing execution date with respect subject matter hereof including confidentiality agreement dated november nbsp between company novartis institute biomedical research affiliate novartis there covenant promise agreement warranty representation condition understanding either oral written between party other than forth herein notwithstanding authority granted subcommittee under this agreement subsequent alteration amendment change addition this agreement shall binding upon party unless reduced writing signed authorized officer each party style margin margin bottom text indent font size font family time roman force majeure event that either party prevented from performing obligation under this agreement result contingency beyond reasonable control force majeure including action governmental authority agency terrorism hostility between nation civil commotion riot strike lockout sabotage shortage supply only extent such shortage caused nonperforming party energy shortage fire flood nature such typhoon hurricane earthquake tsunami party affected shall responsible other party delay failure performance obligation hereunder long force majeure prevents such performance event force majeure party immediately affected thereby shall give prompt written notice other party specifying force majeure event complained shall commercially reasonable effort resume performance obligation style margin margin bottom text indent font size font family time roman notice notice consent waiver other communication under this agreement must writing will deemed have been duly given when nbsp delivered style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman hand with written confirmation receipt nbsp sent with written confirmation receipt provided that copy immediately sent internationally recognized overnight delivery service receipt requested nbsp when received addressee sent internationally recognized overnight delivery service receipt requested each case appropriate address number forth below such other address number party designate notice style margin margin bottom text indent font size font family time roman company style margin margin bottom margin left font size font family time roman aduro biotech style margin margin bottom margin left font size font family time roman bancroft style margin margin bottom margin left font size font family time roman berkeley style margin margin bottom margin left font size font family time roman attention style margin margin bottom margin left font size font family time roman office style margin margin bottom text indent font size font family time roman with copy which shall constitute notice style margin margin bottom margin left font size font family time roman arnold nbsp porter style margin margin bottom margin left font size font family time roman park avenue style margin margin bottom margin left font size font family time roman york style margin margin bottom margin left font size font family time roman attention blaine templeman style margin margin bottom margin left font size font family time roman office style margin margin bottom text indent font size font family time roman novartis style margin margin bottom margin left font size font family time roman novartis institute biomedical research style margin margin bottom margin left font size font family time roman massachusetts avenue style margin margin bottom margin left font size font family time roman cambridge style margin margin bottom margin left font size font family time roman attention general counsel style margin margin bottom margin left font size font family time roman office style margin margin bottom text indent font size font family time roman with copy which shall constitute notice style margin margin bottom margin left font size font family time roman kaye scholer style margin margin bottom margin left font size font family time roman west street style margin margin bottom margin left font size font family time roman york style margin margin bottom margin left font size font family time roman attention andres liivak style margin margin bottom margin left font size font family time roman office style margin margin bottom font size font family time roman either party change address which notice shall sent giving notice other party manner provided herein style margin margin bottom text indent font size font family time roman construction against drafter heading this agreement been prepared jointly ambiguity this agreement shall construed against party irrespective which party deemed have authored ambiguous provision style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman heading each article section this agreement have been inserted convenience reference only intended limit expand meaning style margin margin bottom text indent font size font family time roman assignment style margin margin bottom text indent font size font family time roman neither party assign right obligation under this agreement without other party prior written consent except that without consent with notice other party nbsp novartis assign right obligation under this agreement part hereof more affiliate nbsp company assign right obligation under this agreement part hereof more affiliate request consent assignment shall unreasonably withheld delayed permitted assignee will assume obligation assignor under this agreement related assigned portion case partial assignment attempted assignment contravention this section nbsp will void subject term this agreement this agreement will binding upon inure benefit party their respective successor permitted assigns style margin margin bottom text indent font size font family time roman each party agrees that notwithstanding provision this agreement contrary style margin margin bottom text indent font size font family time roman either party assign this agreement right obligation license granted hereunder third party connection with change control style margin margin bottom text indent font size font family time roman event that this agreement assigned either party connection with change control such assignment shall provide nbsp assigning party with right access intellectual property right assignee acquirer such party nbsp assignee acquirer with right access intellectual property right assigning party style margin margin bottom text indent font size font family time roman performance affiliate each party discharge obligation exercise right hereunder through affiliate each party hereby guarantee performance affiliate such party obligation under this agreement shall cause affiliate comply with provision this agreement connection with such performance breach party affiliate such party obligation under this agreement shall deemed breach such party other party proceed directly against such party without obligation first proceed against such party affiliate each party shall remain primarily liable omission affiliate style margin margin bottom text indent font size font family time roman further assurance party hereby covenant agree without necessity further consideration execute acknowledge deliver such other document take such other action reasonably necessary carry intent purpose this agreement style margin margin bottom text indent font size font family time roman compliance with each party shall perform obligation under this agreement accordance with applicable including cooperation with filing applicable party shall shall required undertake activity under connection with this agreement which violates which belief good faith violate applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman severability should more provision this agreement become void unenforceable matter then this agreement shall construed such provision were contained herein remainder this agreement shall full force effect party will their commercially reasonable effort substitute invalid unenforceable provision valid enforceable provision which conforms nearly possible with original intent party including nearly possible same economic benefit each party style margin margin bottom text indent font size font family time roman waiver delay enforcing party right under this agreement waiver particular default other matter shall constitute waiver such party right future enforcement right under this agreement except with respect express written signed waiver relating particular matter particular period time style margin margin bottom text indent font size font family time roman relationship party nothing contained this agreement shall deemed constitute partnership joint venture legal entity type between party constitute agent other moreover each party agrees construe this agreement transaction contemplated hereby partnership purpose unless required applicable legislation regulation ruling each party shall solely independent contractor nothing this agreement shall construed give party power authority bind commit other style margin margin bottom text indent font size font family time roman third party beneficiary right provision this agreement sole benefit party their successor permitted assigns agreement shall construed conferring right third party including third party beneficiary right except case article novartis indemnitees company indemnitees applicable style margin margin bottom text indent font size font family time roman english language this agreement written executed english language translation into other language shall official version this agreement event conflict interpretation between english version such translation english version shall prevail style margin margin bottom text indent font size font family time roman expense except otherwise expressly provided this agreement each party shall expense respective lawyer other expert other expense cost incurred such party incidental negotiation preparation execution delivery this agreement style margin margin bottom text indent font size font family time roman counterpart this agreement executed more counterpart each which shall deemed original which together shall constitute same instrument style margin margin bottom font size font family time roman align center remainder page left intentionally blank style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party have executed this agreement duplicate original their duly authorized officer execution date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan aduro biotech valign bottom valign bottom valign bottom valign bottom colspan novartis pharmaceutical corporation style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman stephen isaac valign bottom valign bottom valign bottom valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman bruno strigini style font family time roman font size valign name valign bottom valign bottom stephen isaac valign bottom valign bottom valign bottom valign name valign bottom valign bottom bruno strigini style font family time roman font size valign title valign bottom valign bottom chairman valign bottom valign bottom valign bottom valign title valign bottom valign bottom president novartis oncology table style margin margin bottom font size font family time roman align center signature page collaboration license agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center company patent style margin margin bottom font size font family time roman align center page omitted style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center existing third party license style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center novartis patent style margin margin bottom font size font family time roman align center novartis patent application filed compound disclosed exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center development cost sharing percentage style margin margin bottom font size font family time roman align center page omitted style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center form sublicense agreement style margin margin bottom font size font family time roman align center page omitted style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center complete accurate list license assignment distribution other agreement relating company patent style margin margin bottom font size font family time roman align center page omitted style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center list included within novartis know effective date style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center complete accurate list license assignment distribution other agreement relating novartis patent style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center nbsp style margin margin bottom align center logo style margin margin bottom font size font family time roman march nbsp style margin margin bottom font size font family time roman email style margin margin bottom font size font family time roman bruno strigini style margin margin bottom font size font family time roman president novartis oncology style margin margin bottom font size font family time roman novartis pharmaceutical corporation style margin margin bottom font size font family time roman health plaza style margin margin bottom font size font family time roman east hanover jersey style margin margin bottom font size font family time roman effective date collaboration license agreement style margin margin bottom font size font family time roman dear bruno strigini style margin margin bottom font size font family time roman aduro biotech aduro novartis pharmaceutical corporation novartis party collaboration license agreement entered into march nbsp agreement aduro novartis hereby agree that nbsp section agreement hereby deleted shall further force effect nbsp section nbsp agreement definition term effective date hereby amended replaced entirety following effective date mean march nbsp style margin margin bottom font size font family time roman this letter amendment intended each aduro novartis create hereby creates binding legal agreement which shall enforceable accordance with term agreement continues full force effect accordance with term amended this letter amendment except expressly forth contemplated this letter amendment agreement shall amended hereby please confirm your agreement with foregoing countersigning both copy this letter where indicated returning copy this letter amendment aduro style margin margin bottom font size font family time roman very truly yours style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan aduro nbsp biotech nbsp style font size height height colspan style font family time roman font size valign bottom nowrap nbsp valign bottom valign bottom style border bottom solid style margin margin bottom font size font family time roman nbsp nbsp nbsp nbsp stephen isaac style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp name stephen isaac style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp title chairman nbsp table style margin margin bottom text indent font size font family time roman accepted agreed style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width valign bottom width width style font family time roman font size valign valign bottom valign colspan novartis nbsp pharmaceutical nbsp corporation style font size height height colspan height colspan style font family time roman font size valign valign bottom valign nbsp valign bottom style border bottom solid valign style border bottom solid nbsp nbsp nbsp nbsp bruno strigini style font family time roman font size valign valign bottom valign valign bottom valign bottom nbsp nbsp nbsp nbsp name bruno strigini style font family time roman font size valign valign bottom valign valign bottom valign bottom nbsp nbsp nbsp nbsp title president novartis oncology table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp body html text document